<!DOCTYPE html><html lang="en-GB"><head><meta charSet="utf-8"/><meta http-equiv="x-ua-compatible" content="ie=edge"/><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"/><style data-href="/component---src-templates-chapter-level-2-chapter-level-2-tsx.d09ef71dfbb262c31a03.css" id="gatsby-global-css">.page-header{margin:0 0 3rem}.page-header__pre-heading{font-size:1.125rem;line-height:1.5rem;display:block;margin:0}.page-header__heading{font-size:2.75rem;line-height:3.5rem;margin:0 0 .5rem}.page-header__lead{font-size:1.25rem;line-height:1.75rem;margin:0 0 .5rem}.page-header__cta{font-size:1rem;line-height:1.5rem;display:block;margin:0}@media print{.page-header__cta{display:none!important}}.breadcrumbs{font-size:1rem;line-height:1.5rem;list-style:none;margin:.5em 0 2em;max-width:100%;padding:0}@media print{.breadcrumbs{display:none!important}}.breadcrumbs__crumb{display:inline-block}.breadcrumbs__crumb:before{content:">";font-size:80%;margin:0 .25em}.breadcrumbs__crumb:first-child:before{display:none}.breadcrumbs a{color:#222;text-decoration:underline}.breadcrumbs a:hover{text-decoration:none}.breadcrumbs a:focus{color:#005ea5}.breadcrumbs a:active{color:#222}.OldIEMessage-module--container--2Z9pT{max-width:73.125rem;width:96%;width:-webkit-calc(100% - 2rem);width:calc(100% - 2rem);margin:auto auto 1rem}.OldIEMessage-module--alert--3CB3M{background:#ffdfa4;border:1px solid #966f2f;margin:1rem auto 0;max-width:73.125rem;padding:1rem}.OldIEMessage-module--alert--3CB3M a{color:#005ea5;-webkit-tap-highlight-color:rgba(0,146,166,.333);text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}.OldIEMessage-module--alert--3CB3M a:visited{color:#4c2c92}.OldIEMessage-module--alert--3CB3M a:hover{color:#2e8aca}.OldIEMessage-module--alert--3CB3M a:focus{outline:.25rem solid #0092a6;color:#005ea5}.OldIEMessage-module--alert--3CB3M a:active{color:#222}.OldIEMessage-module--alert--3CB3M h2{margin-top:0}.OldIEMessage-module--alert--3CB3M h2,.OldIEMessage-module--alert--3CB3M p{max-width:600px}.OldIEMessage-module--lastP---CQws{margin-bottom:0}.CoronaMessage-module--wrapper--zRiaV{background:#ffeb3b;padding:.5rem 0}.CoronaMessage-module--wrapper--zRiaV p{margin-top:0}.CoronaMessage-module--wrapper--zRiaV a{color:#005ea5;-webkit-tap-highlight-color:rgba(0,146,166,.333);text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}.CoronaMessage-module--wrapper--zRiaV a:visited{color:#4c2c92}.CoronaMessage-module--wrapper--zRiaV a:hover{color:#2e8aca}.CoronaMessage-module--wrapper--zRiaV a:focus{outline:.25rem solid #0092a6;color:#005ea5}.CoronaMessage-module--wrapper--zRiaV a:active{color:#222}@media print{.CoronaMessage-module--wrapper--zRiaV{display:none}}.CoronaMessage-module--container--36Biz{margin:auto;max-width:73.125rem;width:96%;width:-webkit-calc(100% - 2rem);width:calc(100% - 2rem)}.CoronaMessage-module--container--36Biz>:last-child{margin-bottom:0}.SubNav-module--wrapper--yAXWY{background:#fff;color:#000;display:block}.SubNav-module--list--1K9bK{margin:0;padding:0}.SubNav-module--list--1K9bK li{list-style:none;margin:0}.SubNav-module--link--39i23{border-color:#004650;border-style:solid;border-width:0 .25rem;color:#222;display:block;font-weight:400;padding:.5rem 1rem .5rem 2rem;text-decoration:none}.SubNav-module--link--39i23:focus{color:#222;outline:.25rem solid #0092a6;outline-offset:-.5rem}.SubNav-module--link--39i23:active,.SubNav-module--link--39i23:hover,.SubNav-module--link--39i23:visited{border-color:#004650;border-style:solid;border-width:0 .25rem;color:#222}.SubNav-module--link--39i23:hover{background:#d6d6d6;color:#222;text-decoration:underline}.SubNav-module--imageLink--3xwIS{display:none}@media(min-width:56.25em){.SubNav-module--wrapper--yAXWY{border-bottom:.125rem solid #004650;bottom:0;height:3rem;left:0;position:absolute;width:100%}.SubNav-module--imageLink--3xwIS{display:inline-block}.SubNav-module--list--1K9bK{margin:auto;max-width:73.125rem;width:96%;width:-webkit-calc(100% - 2rem);width:calc(100% - 2rem);height:100%}.SubNav-module--list--1K9bK li{display:inline-block;height:100%;vertical-align:middle}.SubNav-module--link--39i23{border:0;display:block;height:100%;padding:0 1rem}.SubNav-module--link--39i23[aria-current=page],.SubNav-module--link--39i23[aria-current=true]{background:transparent}.SubNav-module--link--39i23[aria-current=page]:after,.SubNav-module--link--39i23[aria-current=true]:after{display:none}.SubNav-module--link--39i23:before{content:"";display:inline-block;height:100%;vertical-align:middle}.SubNav-module--link--39i23:active,.SubNav-module--link--39i23:hover,.SubNav-module--link--39i23:visited{border:0}}.SubNav-module--image--uq-a2{height:100%}.Nav-module--link--3JzDA .Nav-module--tooltip--1Uj-W{clip:rect(1px 1px 1px 1px);clip:rect(1px,1px,1px,1px);height:1px;overflow:hidden;position:absolute;width:1px}.Nav-module--link--3JzDA:focus-visible .Nav-module--tooltip--1Uj-W{background:#fff;clip:auto;color:#005ea5;display:block;height:auto;outline:1px solid #0092a6;overflow:visible;padding:0 .25rem;position:absolute;width:auto;z-index:1}.Nav-module--visuallyHidden--ORHqX{clip:rect(0,0,0,0);height:1px;overflow:hidden;position:absolute!important;width:1px}.Nav-module--wrapper--2_xng{display:none;position:relative}@media print{.Nav-module--wrapper--2_xng{display:none!important}}@media(min-width:56.25em){.Nav-module--wrapper--2_xng{display:block}}.Nav-module--wrapperExpanded--3RxQB{display:block}.Nav-module--nav--2aQpa abbr[title]{border-bottom:0;cursor:help;text-decoration:none}.Nav-module--myAccount--3lsif{border-top:1px solid #fff}@media(min-width:56.25em){.Nav-module--myAccount--3lsif{display:none}}.Nav-module--myAccountHeading--1A5_B{border:.25rem solid #004650;font-size:100%;margin:0;padding:.5rem 1rem}.Nav-module--menuWrapper--2fp8S{background:#004650;color:#fff;padding:.25rem 0}.Nav-module--menuList--264L-{list-style:none;margin:auto;padding:0}.Nav-module--menuList--264L->li{margin:0}a.Nav-module--link--3JzDA{border-color:#004650;border-style:solid;border-width:0 .25rem;color:#fff;display:block;font-weight:400;padding:.5rem 1rem;text-decoration:none}a.Nav-module--link--3JzDA span{text-decoration:inherit}a.Nav-module--link--3JzDA:focus{color:#fff;outline:.25rem solid #fff;outline-offset:-.5rem;z-index:1}a.Nav-module--link--3JzDA:visited{color:#fff}a.Nav-module--link--3JzDA:active{background:#acadad;color:#222}a.Nav-module--link--3JzDA:hover{background:#d6d6d6;color:#222;text-decoration:underline}a.Nav-module--link--3JzDA[aria-current=page],a.Nav-module--link--3JzDA[aria-current=true]{background:#fff;color:#222;font-weight:700}a.Nav-module--link--3JzDA[aria-current=page]:focus,a.Nav-module--link--3JzDA[aria-current=true]:focus{outline-color:#0092a6;outline-offset:-.25rem}@media(min-width:56.25em){.Nav-module--wrapperWithSubLinks--3PUfX{padding-bottom:3rem}.Nav-module--menuList--264L-{margin:auto;max-width:73.125rem;width:96%;width:-webkit-calc(100% - 2rem);width:calc(100% - 2rem);display:-webkit-flex;display:flex;-webkit-flex-direction:row;flex-direction:row;-webkit-flex-wrap:nowrap;flex-wrap:nowrap;-webkit-justify-content:space-between;justify-content:space-between}.Nav-module--menuList--264L->li{-webkit-flex-grow:1;flex-grow:1}a.Nav-module--link--3JzDA{border-left-width:0;border-right-width:0;display:-webkit-flex;display:flex;-webkit-flex-direction:column;flex-direction:column;height:100%;-webkit-justify-content:center;justify-content:center;line-height:1.25;margin:0;padding:.5rem;position:relative;text-align:center}a.Nav-module--link--3JzDA:focus{outline-offset:-.25rem}a.Nav-module--link--3JzDA span{display:inline-block;vertical-align:middle;white-space:normal}a.Nav-module--link--3JzDA[aria-current=page],a.Nav-module--link--3JzDA[aria-current=true]{margin:0 .25rem}a.Nav-module--link--3JzDA[aria-current=page]:focus,a.Nav-module--link--3JzDA[aria-current=true]:focus{outline-offset:-.5rem}a.Nav-module--link--3JzDA[aria-current=page]:after,a.Nav-module--link--3JzDA[aria-current=true]:after{background:#fff;content:"";display:block;height:.25rem;left:0;position:absolute;top:100%;width:100%}a.Nav-module--link--3JzDA[aria-current=page]:hover:after,a.Nav-module--link--3JzDA[aria-current=true]:hover:after{background:#d6d6d6}}@media(min-width:56.25em)and (min-width:75em){a.Nav-module--link--3JzDA{padding:1rem}}.Autocomplete-module--ac--2PqiF .autocomplete__wrapper{position:relative}.Autocomplete-module--ac--2PqiF .autocomplete__hint,.Autocomplete-module--ac--2PqiF .autocomplete__input{-webkit-appearance:none;border:1px solid #222;border-radius:0;box-sizing:border-box;margin-bottom:0;width:100%}.Autocomplete-module--ac--2PqiF .autocomplete__input{background-color:#e9e9e9!important;height:2.5rem!important;margin:0!important;max-width:100%!important;position:relative;z-index:101}.Autocomplete-module--ac--2PqiF .autocomplete__input:focus{outline:3px solid #0092a6;outline-offset:-3px;z-index:1}.Autocomplete-module--ac--2PqiF .autocomplete__input::-webkit-input-placeholder{color:#666!important;font-size:100%;font-weight:400;opacity:1}.Autocomplete-module--ac--2PqiF .autocomplete__input::-moz-placeholder{color:#666!important;font-size:100%;font-weight:400;opacity:1}.Autocomplete-module--ac--2PqiF .autocomplete__input:-ms-input-placeholder{color:#666!important;font-size:100%;font-weight:400;opacity:1}.Autocomplete-module--ac--2PqiF .autocomplete__input::-ms-input-placeholder{color:#666!important;font-size:100%;font-weight:400;opacity:1}.Autocomplete-module--ac--2PqiF .autocomplete__input::placeholder{color:#666!important;font-size:100%;font-weight:400;opacity:1}.Autocomplete-module--ac--2PqiF .autocomplete__hint{color:#bfc1c3;position:absolute}.Autocomplete-module--ac--2PqiF .autocomplete__input--default{padding:.5rem}.Autocomplete-module--ac--2PqiF .autocomplete__input--focused{outline:3px solid #0092a6;outline-offset:-3px}.Autocomplete-module--ac--2PqiF .autocomplete__input--show-all-values{padding:4px 34px 4px 4px;cursor:pointer}.Autocomplete-module--ac--2PqiF .autocomplete__dropdown-arrow-down{z-index:-1;display:inline-block;position:absolute;right:8px;width:24px;height:24px;top:10px}.Autocomplete-module--ac--2PqiF .autocomplete__menu{background-color:#fff;border:1px solid #d6d6d6;border-top:0;color:#34384b;margin:0;max-width:100%;padding:0;text-align:left;width:-webkit-calc(100vw - 2rem);width:calc(100vw - 2rem)}@media(min-width:37.5em){.Autocomplete-module--ac--2PqiF .autocomplete__menu{width:100%}}.Autocomplete-module--ac--2PqiF .autocomplete__menu--visible{display:block}.Autocomplete-module--ac--2PqiF .autocomplete__menu--hidden{display:none}.Autocomplete-module--ac--2PqiF .autocomplete__menu--overlay{box-shadow:0 .25rem 1rem .25rem rgba(0,0,0,.1);left:0;position:absolute;top:100%;z-index:100}.Autocomplete-module--ac--2PqiF .autocomplete__menu--inline{position:relative}.Autocomplete-module--ac--2PqiF .autocomplete__option{border-left-width:0;border-bottom:1px solid #d6d6d6;border-right-width:0;border-top-width:1px;color:#005ea5;cursor:pointer;display:block;margin:0;position:relative}.Autocomplete-module--ac--2PqiF .autocomplete__option a{color:inherit;display:block;font-weight:400;padding:.5rem;text-decoration:none}.Autocomplete-module--ac--2PqiF .autocomplete__option mark{background:0;color:inherit;font-weight:700;padding:0}.Autocomplete-module--ac--2PqiF .autocomplete__option>*{pointer-events:none}.Autocomplete-module--ac--2PqiF .autocomplete__option:first-of-type{border-top-width:0}.Autocomplete-module--ac--2PqiF .autocomplete__option:last-of-type{border-bottom-width:0}.Autocomplete-module--ac--2PqiF .autocomplete__option--odd{background-color:#fafafa}.Autocomplete-module--ac--2PqiF .autocomplete__option--focused,.Autocomplete-module--ac--2PqiF .autocomplete__option:hover{background-color:#e9e9e9;color:#005ea5;outline:none;text-decoration:underline}.Autocomplete-module--ac--2PqiF .autocomplete__option--no-results{background-color:#fafafa;color:#646b6f;cursor:not-allowed}.Autocomplete-module--ac--2PqiF .autocomplete__hint,.Autocomplete-module--ac--2PqiF .autocomplete__input,.Autocomplete-module--ac--2PqiF .autocomplete__option{font-size:16px;line-height:1.25}.Search-module--search--2wNll{margin:0;padding-right:2.5rem;position:relative}.Search-module--label--1rrog{clip:rect(1px 1px 1px 1px);clip:rect(1px,1px,1px,1px);height:1px;overflow:hidden;position:absolute!important;width:1px}.Search-module--button--2FbnI{background:#393939;border:0;color:#fff;cursor:pointer;height:2.5rem;min-width:2.5rem;padding:0 .5rem;position:absolute;right:0;text-align:center;top:0;z-index:101}.Search-module--button--2FbnI:focus{outline:.25rem solid #0092a6}.Search-module--button--2FbnI .Search-module--icon--2JB42{font-size:150%;vertical-align:middle}.Account-module--account--1BtRh{position:relative}.Account-module--button--zZii1{background:#fff;border:1px solid #222;color:#222;cursor:pointer;display:inline-block;font-family:inherit;font-size:inherit;font-weight:400;height:2.5rem;line-height:2.5rem;padding:0 .5rem;text-decoration:none;vertical-align:middle;white-space:nowrap}.Account-module--button--zZii1:focus{outline:.25rem solid #0092a6}.Account-module--button--zZii1:visited{color:#222}.Account-module--button--zZii1:hover{border:1px solid #222}.Account-module--myAccount--3jTaq:after{border-left:.25rem solid transparent;border-right:.25rem solid transparent;border-top:.5rem solid #393939;content:"";display:inline-block;height:0;margin-left:.5rem;vertical-align:middle;width:0}.Account-module--myAccount--3jTaq[aria-expanded=true]:after{border-bottom:.5rem solid #222;border-top:0}.Account-module--menu--3C46i{background:#fff;border:1px solid #393939;list-style:none;margin:.625rem 0 0;padding:0;position:absolute;right:0;top:100%;z-index:2}.Account-module--menu--3C46i:focus{outline:.25rem solid #0092a6}.Account-module--menu--3C46i[aria-hidden=true]{display:none}.Account-module--menu--3C46i:before{border-bottom:.5rem solid #393939;border-left:.25rem solid transparent;border-right:.25rem solid transparent}.Account-module--menu--3C46i:after,.Account-module--menu--3C46i:before{bottom:100%;content:"";display:block;height:0;position:absolute;right:1rem;width:0}.Account-module--menu--3C46i:after{border-bottom:.4rem solid #fff;border-left:.2rem solid transparent;border-right:.2rem solid transparent;margin-right:1px}.Account-module--menu--3C46i li{border-top:1px solid #d6d6d6;list-style:none;margin:0}.Account-module--menu--3C46i a{color:#005ea5;display:block;padding:.5rem 1rem;text-decoration:none;white-space:nowrap}.Account-module--menu--3C46i a:focus{outline:.25rem solid #0092a6}.Account-module--menu--3C46i a:hover{background:#e9e9e9;text-decoration:underline}.Header-module--header--3os44{background:#fff;border-bottom:.125rem solid #004650;box-sizing:border-box;font-family:Lato,Helvetica Neue,Helvetica,Arial,sans-serif}.Header-module--header--3os44 *,.Header-module--header--3os44 :after,.Header-module--header--3os44 :before{box-sizing:inherit;font-family:inherit}@media print{.Header-module--header--3os44{border-bottom:none}}.Header-module--container--1mfIr{margin:auto;max-width:73.125rem;width:96%;width:-webkit-calc(100% - 2rem);width:calc(100% - 2rem);padding:1rem 0 0}.Header-module--container--1mfIr:after{clear:both;content:"";display:table}.Header-module--home--1TCPb{color:#000;display:inline-block;float:left;height:1.875rem;margin-bottom:1rem}@media print{.Header-module--home--1TCPb:after{content:none!important}}.Header-module--home--1TCPb:focus{outline:.25rem solid #0092a6}.Header-module--home--1TCPb:visited{color:#000}.Header-module--home--1TCPb .Header-module--icon--4LSt5{height:100%;width:auto}.Header-module--wrapper--2e13D{display:-webkit-flex;display:flex;-webkit-flex-grow:1;flex-grow:1;float:right;-webkit-justify-content:space-between;justify-content:space-between;margin-bottom:1rem;width:50%}@media print{.Header-module--wrapper--2e13D{display:none!important}}.Header-module--wrapper--2e13D:after{clear:both;content:"";display:table}.Header-module--search--2nfnz{-webkit-flex-grow:1;flex-grow:1;float:left;margin-right:1rem;min-width:66.6666666667%}.Header-module--mobileMenuBtn--1LgyL{-webkit-appearance:none;-moz-appearance:none;appearance:none;background:none;border:1px solid #222;float:right;font-family:inherit;font-size:110%;height:2.5rem;min-width:4.6875rem;white-space:nowrap}.Header-module--mobileMenuBtn--1LgyL:after{border-left:.25rem solid transparent;border-right:.25rem solid transparent;border-top:.5rem solid #393939;content:"";display:inline-block;height:0;margin-left:.5rem;vertical-align:middle;width:0}.Header-module--mobileMenuBtn--1LgyL[aria-expanded=true]:after{border-bottom:.5rem solid #222;border-top:0}.Header-module--account--y72Q4{display:none}@media(max-width:56.24em){.Header-module--home--1TCPb{float:none}.Header-module--wrapper--2e13D{float:none;width:auto}}@media(min-width:56.25em){.Header-module--header--3os44{border-bottom:.25rem solid #fff}.Header-module--container--1mfIr{display:-webkit-flex;display:flex;-webkit-justify-content:space-between;justify-content:space-between}.Header-module--home--1TCPb{height:2.5rem;margin-right:2rem}.Header-module--wrapper--2e13D{-webkit-justify-content:flex-end;justify-content:flex-end}.Header-module--search--2nfnz{margin-right:2rem}.Header-module--mobileMenuBtn--1LgyL{display:none}.Header-module--account--y72Q4{display:block}}.SkipLinks-module--list--1WwLa{list-style:none;margin:0;padding:0}@media print{.SkipLinks-module--list--1WwLa{display:none!important}}.SkipLinks-module--list--1WwLa li{list-style:none;margin:0}.SkipLinks-module--link--hkZw8{clip:rect(1px 1px 1px 1px);clip:rect(1px,1px,1px,1px);height:1px;overflow:hidden;position:absolute;width:1px}.SkipLinks-module--link--hkZw8:focus{background:#fff;clip:auto;color:#005ea5;display:block;height:auto;left:.25rem;outline:3px solid #0092a6;overflow:visible;padding:.5rem 1rem;position:absolute;top:.25rem;white-space:nowrap;width:auto;z-index:1}.Social-module--wrapper--2nKsd{clear:left}.Social-module--list--E5R5J{list-style:none;margin:0;max-width:100%;padding:0}.Social-module--list--E5R5J li{margin:0 0 .25rem}.Social-module--list--E5R5J svg{margin:-.125rem .25rem 0 0;vertical-align:middle}@media(min-width:37.5em){.Social-module--list--E5R5J li{float:left;margin:0 1rem 0 0}}@media(min-width:56.25em){.Social-module--wrapper--2nKsd{clear:none}.Social-module--wrapper--2nKsd li{float:none;margin:0 0 .25rem}}.Legal-module--wrapper--3AYMO{font-size:.875rem;line-height:1.25rem;background:#393939;padding:1rem 0}.Legal-module--wrapper--3AYMO a{text-decoration:underline}.Legal-module--container--3TTBh{margin:auto;max-width:73.125rem;width:96%;width:-webkit-calc(100% - 2rem);width:calc(100% - 2rem)}.Legal-module--menu--1e1Iy{margin:0 0 1rem}@media print{.Legal-module--menu--1e1Iy{display:none!important}}.Legal-module--menu--1e1Iy ul{list-style:none;margin:0;max-width:100%;padding:0}.Legal-module--menu--1e1Iy li{margin:0}.Legal-module--menu--1e1Iy a{display:block}.Legal-module--copyright--34nsI{font-size:.875rem;line-height:1.25rem;margin:0}@media print{.Legal-module--copyright--34nsI{float:none!important;max-width:100%}}@media(min-width:37.5em){.Legal-module--menu--1e1Iy li{display:inline-block;margin-right:1rem}}@media(min-width:75em){.Legal-module--wrapper--3AYMO:after,.Legal-module--wrapper--3AYMO:before{content:" ";display:table}.Legal-module--wrapper--3AYMO:after{clear:both}.Legal-module--menu--1e1Iy{float:left;margin:0}.Legal-module--copyright--34nsI{float:right}}.Services-module--link--2y_1q .Services-module--tooltip--pg3nW{clip:rect(1px 1px 1px 1px);clip:rect(1px,1px,1px,1px);height:1px;overflow:hidden;position:absolute;width:1px}.Services-module--link--2y_1q:focus-visible .Services-module--tooltip--pg3nW{background:#fff;clip:auto;color:#005ea5;display:block;height:auto;outline:1px solid #0092a6;overflow:visible;padding:0 .25rem;position:absolute;width:auto;z-index:1}.Services-module--visuallyHidden--t9mfm{clip:rect(0,0,0,0);height:1px;overflow:hidden;position:absolute!important;width:1px}.Services-module--wrapper--2qOoE{margin:0 0 2rem}.Services-module--list--3SZQu{list-style:none;margin:0;padding:0}.Services-module--list--3SZQu li{margin:0 0 .25rem}@media(min-width:37.5em){.Services-module--wrapper--2qOoE{border-right:2px solid #393939;float:left;width:33.3333333333%}}@media(min-width:56.25em){.Services-module--wrapper--2qOoE{border-right:2px solid #393939;float:left;margin:0;width:25%}}.Pages-module--wrapper--30REl{margin:0 0 2rem}.Pages-module--list--vvSk4{list-style:none;margin:0;padding:0}.Pages-module--list--vvSk4 li{margin:0 0 .25rem}@media(min-width:25em){.Pages-module--list--vvSk4{-webkit-column-count:2;-moz-column-count:2;column-count:2;-webkit-column-gap:1rem;-moz-column-gap:1rem;column-gap:1rem}}@media(min-width:37.5em){.Pages-module--wrapper--30REl{float:left;margin:0;padding:0 0 0 2rem;width:66.6666666667%}}@media(min-width:56.25em){.Pages-module--wrapper--30REl{float:left;margin:0;padding:0 2rem;width:50%}.Pages-module--list--vvSk4{-webkit-column-count:2;-moz-column-count:2;column-count:2;-webkit-column-gap:1rem;-moz-column-gap:1rem;column-gap:1rem}}.Footer-module--link--CGIYk .Footer-module--tooltip--1zoJv{clip:rect(1px 1px 1px 1px);clip:rect(1px,1px,1px,1px);height:1px;overflow:hidden;position:absolute;width:1px}.Footer-module--link--CGIYk:focus-visible .Footer-module--tooltip--1zoJv{background:#fff;clip:auto;color:#005ea5;display:block;height:auto;outline:1px solid #0092a6;overflow:visible;padding:0 .25rem;position:absolute;width:auto;z-index:1}.Footer-module--visuallyHidden--3CCnP{clip:rect(0,0,0,0);height:1px;overflow:hidden;position:absolute!important;width:1px}.Footer-module--footer--2QrGZ{background:#222;box-sizing:border-box;color:#fff;contain-intrinsic-size:350px;content-visibility:auto;font-family:Lato,Helvetica Neue,Helvetica,Arial,sans-serif;margin:2rem 0 0}.Footer-module--footer--2QrGZ a{color:#fff;-webkit-tap-highlight-color:rgba(0,146,166,.333);text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}.Footer-module--footer--2QrGZ a:visited{color:#fff}.Footer-module--footer--2QrGZ a:hover{color:#d6d6d6}.Footer-module--footer--2QrGZ a:focus{outline:.25rem solid #fff;color:#fff}.Footer-module--footer--2QrGZ a:active{color:#d6d6d6}.Footer-module--footer--2QrGZ *,.Footer-module--footer--2QrGZ :after,.Footer-module--footer--2QrGZ :before{box-sizing:inherit}.Footer-module--footer--2QrGZ a{font-weight:400}.Footer-module--container--1iuoB{margin:auto;max-width:73.125rem;width:96%;width:-webkit-calc(100% - 2rem);width:calc(100% - 2rem);padding:1rem 0}.Footer-module--container--1iuoB:after,.Footer-module--container--1iuoB:before{content:" ";display:table}.Footer-module--container--1iuoB:after{clear:both}@media print{.Footer-module--container--1iuoB{display:none!important}}.Footer-module--logo--3DGKv{display:block;height:0;margin:0 0 2rem;padding:0 0 29.0496453901px;position:relative;width:80px}.Footer-module--logo--3DGKv svg{display:block;height:100%!important;left:0;position:absolute;top:0;width:100%!important}@media(min-width:56.25em){.Footer-module--logo--3DGKv{margin-bottom:1rem}}.BackToTop-module--wrapper--2Z0EU{margin-top:3rem}@media print{.BackToTop-module--wrapper--2Z0EU{display:none}}.BackToTop-module--nav--1DPZ6{background:#e9e9e9;border-top:1px solid #adadad;width:100%;z-index:1}.BackToTop-module--anchor--1Nia6{display:block;line-height:1rem;padding:1rem 0}.BackToTop-module--anchor--1Nia6:visited{color:#005ea5}.BackToTop-module--anchor--1Nia6 svg{-webkit-transition:all .25s ease;transition:all .25s ease}.BackToTop-module--anchor--1Nia6:hover{background:#f4f4f4}.BackToTop-module--anchor--1Nia6:hover svg{-webkit-transform:translateY(-.125rem);transform:translateY(-.125rem)}@supports((position:-webkit-sticky) or (position:sticky)){.BackToTop-module--wrapper--2Z0EU{bottom:0;left:0;margin:0;pointer-events:none;position:absolute;right:0;top:min(100vh,-webkit-calc(100% - 3rem));top:min(100vh,calc(100% - 3rem));width:100%;z-index:99}.BackToTop-module--nav--1DPZ6{position:-webkit-sticky;position:sticky;pointer-events:all;top:-webkit-calc(100vh - 3rem);top:calc(100vh - 3rem);background:#e9e9e9;border-top:1px solid #adadad;width:100%;z-index:1}}@font-face{font-display:optional;font-family:Lato;font-style:normal;font-weight:400;src:local("Lato"),url(../../../../fonts/lato-v17-latin-regular.woff2) format("woff2"),url(../../../../fonts/lato-v17-latin-regular.woff) format("woff")}@font-face{font-display:optional;font-family:Lato;font-style:italic;font-weight:400;src:local("Lato"),url(../../../../fonts/lato-v17-latin-italic.woff2) format("woff2"),url(../../../../fonts/lato-v17-latin-italic.woff) format("woff")}@font-face{font-display:optional;font-family:Lato;font-style:normal;font-weight:700;src:local("Lato"),url(../../../../fonts/lato-v17-latin-700.woff2) format("woff2"),url(../../../../fonts/lato-v17-latin-700.woff) format("woff")}@font-face{font-display:optional;font-family:Lato;font-style:normal;font-weight:900;src:local("Lato"),url(../../../../fonts/lato-v17-latin-900.woff2) format("woff2"),url(../../../../fonts/lato-v17-latin-900.woff) format("woff")}/*! normalize.css v8.0.1 | MIT License | github.com/necolas/normalize.css */html{line-height:1.15;-webkit-text-size-adjust:100%}body{margin:0}main{display:block}h1{font-size:2em;margin:.67em 0}hr{box-sizing:content-box;height:0;overflow:visible}pre{font-family:monospace,monospace;font-size:1em}a{background-color:transparent}abbr[title]{border-bottom:none;text-decoration:underline;-webkit-text-decoration:underline dotted;text-decoration:underline dotted}b,strong{font-weight:bolder}code,kbd,samp{font-family:monospace,monospace;font-size:1em}small{font-size:80%}sub,sup{font-size:75%;line-height:0;position:relative;vertical-align:baseline}sub{bottom:-.25em}sup{top:-.5em}img{border-style:none}button,input,optgroup,select,textarea{font-family:inherit;font-size:100%;line-height:1.15;margin:0}button,input{overflow:visible}button,select{text-transform:none}[type=button],[type=reset],[type=submit],button{-webkit-appearance:button}[type=button]::-moz-focus-inner,[type=reset]::-moz-focus-inner,[type=submit]::-moz-focus-inner,button::-moz-focus-inner{border-style:none;padding:0}[type=button]:-moz-focusring,[type=reset]:-moz-focusring,[type=submit]:-moz-focusring,button:-moz-focusring{outline:1px dotted ButtonText}fieldset{padding:.35em .75em .625em}legend{box-sizing:border-box;color:inherit;display:table;max-width:100%;padding:0;white-space:normal}progress{vertical-align:baseline}textarea{overflow:auto}[type=checkbox],[type=radio]{box-sizing:border-box;padding:0}[type=number]::-webkit-inner-spin-button,[type=number]::-webkit-outer-spin-button{height:auto}[type=search]{-webkit-appearance:textfield;outline-offset:-2px}[type=search]::-webkit-search-decoration{-webkit-appearance:none}::-webkit-file-upload-button{-webkit-appearance:button;font:inherit}details{display:block}summary{display:list-item}[hidden],template{display:none}.show-print{display:none!important}@media print{.show-print{display:block!important}}@media print{.hide-print{display:none!important}}@media print{.remove-appended-print-link:after{content:none!important}}@media print{*{background:transparent!important;box-shadow:none!important;color:#000!important;text-shadow:none!important}a,a:visited{text-decoration:underline}}@media print{h1 a:after,h2 a:after,h3 a:after,h4 a:after,h5 a:after,h6 a:after{content:none!important}}@media print{a[href]:after{content:" (" attr(href) ")"}}@media print{abbr[title]:after{content:" (" attr(title) ")"}}@media print{.ir a:after,a[href^="#"]:after,a[href^="javascript:"]:after{content:""}}@media print{blockquote,pre{border:1px solid #999;page-break-inside:avoid}}@media print{thead{display:table-header-group}}@media print{img,tr{page-break-inside:avoid}}@media print{img{max-width:100%!important}}@media print{img:not([alt]),img[alt=""]{display:none!important}}@media print{@page{margin:.5cm}}@media print{h2,h3,p{orphans:3;widows:3}}@media print{h2,h3{page-break-after:avoid}}.clearfix:after,.clearfix:before{content:" ";display:table}.clearfix:after{clear:both}.container{margin:auto;max-width:73.125rem;width:96%;width:-webkit-calc(100% - 2rem);width:calc(100% - 2rem)}.container--full{max-width:100%;padding:0 2%;width:auto}html{box-sizing:border-box;font-size:.9375rem;overflow-x:hidden}html *,html :after,html :before{box-sizing:inherit}@media(min-width:56.25em){html{font-size:1.03125rem;font-size:-webkit-calc(.375rem + 1vw);font-size:calc(.375rem + 1vw)}}@media(min-width:75em){html{font-size:1.125rem}}body{background:#f4f4f4;color:#222;font-family:Lato,Helvetica Neue,Helvetica,Arial,sans-serif;font-style:normal;line-height:1.5rem;overflow-x:hidden;text-rendering:optimizelegibility}img{max-width:100%}hr{background:0;border:0;border-top:.0625em solid #adadad;margin:2em 0;padding:0}.p,p{font-size:1rem;line-height:1.5rem;font-feature-settings:"kern","onum","liga"}.lead,.p,p{margin-bottom:1rem;margin-top:1rem;font-weight:400;max-width:66ch}.lead{font-size:1.25rem;line-height:1.75rem}code{background:#e9e9e9;border:1px solid #adadad;border-radius:.125em;color:#222;display:inline-block;font-family:Monaco,Menlo,Consolas,Courier New,monospace;margin:0 0 .125em;padding:0 .25em}pre code{background:transparent;border:0;margin:0}.mark,mark{background-color:#fff999;padding:0 .25em}.small,small{font-size:85%}.h6,h6{font-size:1rem}.h5,.h6,h5,h6{line-height:1.5rem;margin-bottom:1rem;margin-top:1rem;clear:both;font-weight:700;max-width:66ch}.h5,h5{font-size:1.125rem}.h4,h4{font-size:1.25rem;line-height:1.75rem;margin-bottom:1rem;margin-top:1rem;clear:both;font-weight:700;max-width:66ch}.h3,h3{font-size:1.75rem;line-height:2rem}.h2,.h3,h2,h3{margin-bottom:1rem;margin-top:2rem;clear:both;font-weight:700;max-width:66ch}.h2,h2{font-size:2.25rem;line-height:2.5rem}.h1,.h2+.h3,.h2+h3,h1,h2+.h3,h2+h3{margin-top:0}.h1,h1{font-size:2.75rem;line-height:3.5rem;margin-bottom:1rem;clear:both;font-weight:900;max-width:66ch}.h1+.h2,.h1+h2,h1+.h2,h1+h2{margin-top:0}a{color:#005ea5;-webkit-tap-highlight-color:rgba(0,146,166,.333);text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}a:visited{color:#4c2c92}a:hover{color:#2e8aca}a:focus{outline:.25rem solid #0092a6;color:#005ea5}a:active{color:#222}.link--inverse{color:#fff;-webkit-tap-highlight-color:rgba(0,146,166,.333);text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}.link--inverse:visited{color:#fff}.link--inverse:hover{color:#d6d6d6}.link--inverse:focus{outline:.25rem solid #fff;color:#fff}.link--inverse:active{color:#d6d6d6}.inverse-links a{color:#fff;-webkit-tap-highlight-color:rgba(0,146,166,.333);text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}.inverse-links a:visited{color:#fff}.inverse-links a:hover{color:#d6d6d6}.inverse-links a:focus{outline:.25rem solid #fff;color:#fff}.inverse-links a:active{color:#d6d6d6}.list,ol,ul{font-feature-settings:"kern","onum","liga";margin-left:1rem;max-width:66ch;padding:0}.list--unstyled{list-style:none;margin-left:0;max-width:none;padding:0}.list--loose .list__item,.list--loose li{margin-bottom:.25rem}.list--piped{list-style:none;margin-left:0;padding:0}.list--piped .list__item,.list--piped li{display:inline-block;margin-right:-.25rem}.list--piped .list__item a,.list--piped li a{padding:.5rem}.list--piped .list__item:after,.list--piped li:after{border-left:1px solid #004650;content:"\200B";display:inline-block;margin:0 .5em;overflow:hidden;text-indent:-99px;vertical-align:middle;width:0}.list--piped .list__item:first-child a,.list--piped li:first-child a{padding-left:0}.list--piped .list__item:last-child:after,.list--piped li:last-child:after{display:none}.quote{font-size:1.25rem;line-height:1.75rem;border-left:.25em solid #004650;font-weight:400;margin:2rem 0;padding:0 0 0 4rem;position:relative}.quote:before{color:#004650;content:"\201C";display:block;font-family:Arial,sans-serif;font-size:5rem;font-weight:700;left:0;line-height:.8;position:absolute;text-align:center;top:0;width:4rem}@media print{.quote:before{color:#000}}.quote p{font-size:inherit}.quote cite,.quote footer{font-size:1rem;line-height:1.5rem;font-style:normal}table{background:#fff;border:1px solid #adadad;border-collapse:collapse;display:block;margin:0 0 1rem;max-width:100%;overflow-y:hidden;overflow-x:auto;width:100%!important}table th{vertical-align:bottom}table td{vertical-align:top}table td,table th{border:1px solid #adadad;padding:.5rem;text-align:left}table td:first-child,table th:first-child{border-left:0}table td:last-child,table th:last-child{border-right:0}table td p,table th p{margin-top:0}table :not(thead)+tbody tr:first-child th,table tbody tr:first-child th,table thead tr:first-child th{border-top:0}table tbody tr:last-child td{border-bottom:0}table tbody tr:nth-child(2n)>td{background-color:#e9e9e9}html{overflow-x:visible;scroll-behavior:smooth}@media(prefers-reduced-motion){html{scroll-behavior:auto}}body{font-family:Lato,Trebuchet MS,Roboto,Helvetica Neue,Helvetica,Arial,sans-serif;position:relative}.visually-hidden{position:absolute;overflow:hidden;clip:rect(0 0 0 0);height:1px;width:1px;margin:-1px;padding:0;border:0}#content-start:focus{outline:none}footer{margin-top:0!important}@supports((position:-webkit-sticky) or (position:sticky)){.Layout-module--main--1OIFf{position:relative;padding-bottom:4rem}}.stacked-nav{background:#fff;border:1px solid #adadad;margin:0 0 2em}@media print{.stacked-nav{display:none!important}}.stacked-nav__root{font-size:1rem;line-height:1.5rem;border-bottom:1px solid #adadad;font-weight:700;margin:0;max-width:none;position:relative;text-decoration:none}.stacked-nav__root a{color:#222}.stacked-nav__root--no-link{padding:.5em}.stacked-nav__hint{color:#222;display:block}.stacked-nav__hint :active{color:#fff}.stacked-nav__list{list-style:none;margin:0;max-width:100%;padding:0}.stacked-nav__list-item{border-top:1px solid #adadad}.stacked-nav__content-wrapper{display:block}.stacked-nav a{color:#005ea5;display:block;padding:.5em;position:relative;text-decoration:none}.stacked-nav a[aria-current=page],.stacked-nav a[aria-current=true]{background:#e9e9e9;font-weight:700}.stacked-nav a[aria-current=page]:before,.stacked-nav a[aria-current=true]:before{background:#004650;content:"";display:block;height:100%;left:0;position:absolute;top:0;width:.25em}.stacked-nav a:hover{background:#d6d6d6}.stacked-nav a:active{background:#004650;color:#fff}.stacked-nav a:active span{color:#fff}.stacked-nav__nested{list-style:none;margin:0;padding:0}.stacked-nav__nested .stacked-nav__content-wrapper{padding-left:1rem!important}.stacked-nav__nested ul .stacked-nav__content-wrapper{padding-left:2rem!important}.TopicChaptersMenu-module--toggleButton--2MGXA{-webkit-appearance:none;-moz-appearance:none;appearance:none;background:#e9e9e9;border:1px solid #adadad;color:#005ea5;cursor:pointer;display:block;margin:0 0 2rem;padding:1rem 2rem 1rem .5rem;position:relative;text-align:left;width:100%}.TopicChaptersMenu-module--toggleButton--2MGXA:focus{outline:.25rem solid #0092a6;z-index:1}.TopicChaptersMenu-module--toggleButton--2MGXA[aria-expanded=false]+.stacked-nav{display:none}.TopicChaptersMenu-module--toggleButton--2MGXA[aria-expanded=true]{border-bottom:0;margin:0}.TopicChaptersMenu-module--toggleButton--2MGXA[aria-expanded=true]+.stacked-nav{display:block}@media(min-width:37.5em){.TopicChaptersMenu-module--toggleButton--2MGXA{display:none}.TopicChaptersMenu-module--toggleButton--2MGXA[aria-expanded]+.stacked-nav{display:block}}.TopicChaptersMenu-module--icon--27uSj{color:#005ea5;right:.5rem;position:absolute;top:50%;-webkit-transform:translateY(-50%);transform:translateY(-50%)}.ChapterContents-module--wrapper--3ONbu{position:relative}.ChapterContents-module--printBtn--Rk_Zs{color:#005ea5;-webkit-tap-highlight-color:rgba(0,146,166,.333);text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto;-webkit-appearance:none;-moz-appearance:none;appearance:none;background:none;border:0;bottom:100%;cursor:pointer;display:none;padding:0}.ChapterContents-module--printBtn--Rk_Zs:visited{color:#4c2c92}.ChapterContents-module--printBtn--Rk_Zs:hover{color:#2e8aca}.ChapterContents-module--printBtn--Rk_Zs:focus{outline:.25rem solid #0092a6;color:#005ea5}.ChapterContents-module--printBtn--Rk_Zs:active{color:#222}.ChapterContents-module--printBtn--Rk_Zs svg{font-size:1.25rem;line-height:1.75rem;color:#0e0e0e;margin-right:.5rem;vertical-align:text-bottom}.ChapterContents-module--printBtn--Rk_Zs:hover svg{color:#2e8aca}@media(min-width:37.5em){.ChapterContents-module--wrapper--3ONbu:after,.ChapterContents-module--wrapper--3ONbu:before{content:" ";display:table}.ChapterContents-module--wrapper--3ONbu:after{clear:both}.ChapterContents-module--menu--3Epka{float:left;margin-right:1rem;width:-webkit-calc(25% - .5rem);width:calc(25% - .5rem)}.ChapterContents-module--landing--3klSq,.ChapterContents-module--onThisPage--1333P{float:right;width:-webkit-calc(75% - .5rem);width:calc(75% - .5rem)}.ChapterContents-module--body--1XBoo{margin-left:calc(25% + .5rem);overflow:hidden;width:-webkit-calc(75% - .5rem);width:calc(75% - .5rem)}}@media(min-width:56.25em){.ChapterContents-module--printBtn--Rk_Zs{display:block;margin-bottom:3rem;position:absolute;right:0}.ChapterContents-module--menu--3Epka{margin-right:2rem;width:-webkit-calc(25% - 1rem);width:calc(25% - 1rem)}.ChapterContents-module--landing--3klSq{width:-webkit-calc(75% - 1rem);width:calc(75% - 1rem)}.ChapterContents-module--onThisPage--1333P{position:-webkit-sticky;position:sticky;top:0;width:-webkit-calc(16.66667% - 1rem);width:calc(16.66667% - 1rem)}.ChapterContents-module--body--1XBoo{margin-left:calc(25% + 1rem);width:-webkit-calc(58.33333% - 2rem);width:calc(58.33333% - 2rem)}}@media print{.ChapterContents-module--menu--3Epka,.ChapterContents-module--onThisPage--1333P,.ChapterContents-module--printBtn--Rk_Zs{display:none}.ChapterContents-module--body--1XBoo{width:100%}}.ChapterBody-module--wrapper--2HCfk>.visually-hidden:first-child+*>:first-child{margin-top:0}.ChapterBody-module--wrapper--2HCfk h2:focus,.ChapterBody-module--wrapper--2HCfk h3:focus,.ChapterBody-module--wrapper--2HCfk h4:focus,.ChapterBody-module--wrapper--2HCfk h5:focus,.ChapterBody-module--wrapper--2HCfk h6:focus{outline:0!important}.ChapterBody-module--basisWrapper--3JBM_{border:1px solid #adadad;margin-top:1rem;max-width:66ch}.ChapterBody-module--basisWrapper--3JBM_ .ChapterBody-module--headerWrapper--qSIFw>:first-child{margin-top:0}.ChapterBody-module--basisWrapper--3JBM_ .ChapterBody-module--body--2n0CK{padding:0 1rem 1rem}.ChapterBody-module--basisWrapper--3JBM_ .ChapterBody-module--body--2n0CK>:last-child{margin-bottom:0}.ChapterBody-module--headerWrapper--qSIFw{padding:1rem;position:relative}.ChapterBody-module--toggleBtn--3g0p7{color:#005ea5;-webkit-tap-highlight-color:rgba(0,146,166,.333);text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto;-webkit-appearance:none;-moz-appearance:none;appearance:none;background:none;border:0;cursor:pointer;display:block;margin-top:-.5rem;padding:0}.ChapterBody-module--toggleBtn--3g0p7:visited{color:#4c2c92}.ChapterBody-module--toggleBtn--3g0p7:hover{color:#2e8aca}.ChapterBody-module--toggleBtn--3g0p7:focus{outline:.25rem solid #0092a6;color:#005ea5}.ChapterBody-module--toggleBtn--3g0p7:active{color:#222}.ChapterBody-module--toggleBtn--3g0p7:after{content:"";height:100%;left:0;position:absolute;top:0;width:100%}.ChapterBody-module--toggleBtn--3g0p7 svg{font-size:1.125rem;line-height:1.5rem;color:#0e0e0e;margin-right:.5rem;vertical-align:text-bottom}.ChapterBody-module--toggleBtn--3g0p7:hover svg{color:#2e8aca}.ChapterBody-module--body--2n0CK[aria-hidden=true]{display:none}@media print{.ChapterBody-module--basisWrapper--3JBM_ .ChapterBody-module--headerWrapper--qSIFw>:first-child{margin-bottom:0}.ChapterBody-module--basisWrapper--3JBM_ .ChapterBody-module--body--2n0CK[aria-hidden=true]{display:block}.ChapterBody-module--basisWrapper--3JBM_ .ChapterBody-module--toggleBtn--3g0p7{display:none}}.ChapterOnThisPage-module--wrapper--2zc7n{margin-bottom:2rem}.ChapterOnThisPage-module--heading--2SdDN{margin-top:0}.ChapterOnThisPage-module--rootList--2II70{list-style:disc}.ChapterOnThisPage-module--subList--Pwxy9{list-style:circle}.ChapterOnThisPage-module--basisForRecs--1xLSs{display:none}@media(min-width:56.25em){.ChapterOnThisPage-module--heading--2SdDN{font-size:1.25rem;line-height:1.75rem;margin-bottom:1rem;margin-top:0}@supports((position:-webkit-sticky) or (position:sticky)){.ChapterOnThisPage-module--rootList--2II70 a[aria-current=location]{font-weight:700}.ChapterOnThisPage-module--rootList--2II70 a:focus+.ChapterOnThisPage-module--subList--Pwxy9{clip:auto;height:auto;overflow:visible;position:static!important;width:auto}.ChapterOnThisPage-module--subList--Pwxy9{clip:rect(0,0,0,0);height:1px;overflow:hidden;position:absolute!important;width:1px}.ChapterOnThisPage-module--subList--Pwxy9:focus-within{clip:auto;height:auto;overflow:visible;position:static!important;width:auto}.ChapterOnThisPage-module--expandedSubList--1m1WN{clip:auto;height:auto;overflow:visible;position:static!important;width:auto}.ChapterOnThisPage-module--basisForRecs--1xLSs{display:list-item}}}</style><link rel="sitemap" type="application/xml" href="../../../../sitemap.xml"/><title data-react-helmet="true">Scenario: Diarrhoea - prevention and advice for travellers | Management | Diarrhoea - prevention and advice for travellers | CKS | NICE</title><link data-react-helmet="true" rel="search" type="application/opensearchdescription+xml" href="../../../../opensearch.xml" title="CKS"/><link data-react-helmet="true" rel="icon" href="../../../../favicon.ico"/><link data-react-helmet="true" rel="canonical" href="index.html"/><meta data-react-helmet="true" name="description" content="Covers the prevention of travellers&#x27; diarrhoea, and advice for people who are at risk of travellers&#x27; diarrhoea."/><meta data-react-helmet="true" property="og:description" content="Covers the prevention of travellers&#x27; diarrhoea, and advice for people who are at risk of travellers&#x27; diarrhoea."/><meta data-react-helmet="true" property="og:url" content="https://cks.nice.org.uk/topics/diarrhoea-prevention-advice-for-travellers/management/diarrhoea-prevention-advice-for-travellers/"/><meta data-react-helmet="true" property="og:locale" content="en_GB"/><meta data-react-helmet="true" property="og:type" content="website"/><meta data-react-helmet="true" property="og:title" content="Scenario: Diarrhoea - prevention and advice for travellers | Management | Diarrhoea - prevention and advice for travellers | CKS | NICE"/><meta data-react-helmet="true" property="og:image" content="https://cks.nice.org.uk/open-graph-image.png"/><meta data-react-helmet="true" property="og:image:width" content="1200"/><meta data-react-helmet="true" property="og:image:height" content="630"/><meta data-react-helmet="true" name="twitter:card" content="summary"/><meta data-react-helmet="true" name="twitter:image" content="https://cks.nice.org.uk/twitter-summary-image.png"/><meta data-react-helmet="true" name="twitter:image:alt" content="NICE and CKS logos"/><meta data-react-helmet="true" name="twitter:site" content="@NICEcomms"/><meta data-react-helmet="true" name="twitter:creator" content="@NICEcomms"/><meta data-react-helmet="true" name="theme-color" content="#004650"/><script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl+'';f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer', 'GTM-54QC4NL');</script><link rel="manifest" href="../../../../manifest.webmanifest" crossorigin="anonymous"/><meta name="theme-color" content="#004650"/><link rel="apple-touch-icon" sizes="48x48" href="../../../../icons/icon-48x48.png@v=28734348209eeeae5c03a37867f1beb1"/><link rel="apple-touch-icon" sizes="72x72" href="../../../../icons/icon-72x72.png@v=28734348209eeeae5c03a37867f1beb1"/><link rel="apple-touch-icon" sizes="96x96" href="../../../../icons/icon-96x96.png@v=28734348209eeeae5c03a37867f1beb1"/><link rel="apple-touch-icon" sizes="144x144" href="../../../../icons/icon-144x144.png@v=28734348209eeeae5c03a37867f1beb1"/><link rel="apple-touch-icon" sizes="192x192" href="../../../../icons/icon-192x192.png@v=28734348209eeeae5c03a37867f1beb1"/><link rel="apple-touch-icon" sizes="256x256" href="../../../../icons/icon-256x256.png@v=28734348209eeeae5c03a37867f1beb1"/><link rel="apple-touch-icon" sizes="384x384" href="../../../../icons/icon-384x384.png@v=28734348209eeeae5c03a37867f1beb1"/><link rel="apple-touch-icon" sizes="512x512" href="../../../../icons/icon-512x512.png@v=28734348209eeeae5c03a37867f1beb1"/><link as="script" rel="preload" href="../../../../webpack-runtime-28c424ef71f39faedaf0.js"/><link as="script" rel="preload" href="../../../../framework-34da02e39e1f104d9937.js"/><link as="script" rel="preload" href="../../../../app-53a71c38b210970893c4.js"/><link as="script" rel="preload" href="../../../../b95b9d9ffa67e6928854e772968693a58a7317d7-a9e1e5c953d4eee49b87.js"/><link as="script" rel="preload" href="../../../../0ad1f03a47300760909b2ab244b34289611800a7-fa70b32ffeeba2673019.js"/><link as="script" rel="preload" href="../../../../component---src-templates-chapter-level-2-chapter-level-2-tsx-3330d13663fb7ba90e1c.js"/><link as="fetch" rel="preload" href="../../../../page-data/topics/diarrhoea-prevention-advice-for-travellers/management/diarrhoea-prevention-advice-for-travellers/page-data.json" crossorigin="anonymous"/><link as="fetch" rel="preload" href="../../../../page-data/sq/d/3666801979.json" crossorigin="anonymous"/><link as="fetch" rel="preload" href="../../../../page-data/app-data.json" crossorigin="anonymous"/><script src="https://cdn.nice.org.uk/cookie-banner/cookie-banner.min.js" type="text/javascript" async=""></script></head><body><noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54QC4NL" height="0" width="0" style="display: none; visibility: hidden" aria-hidden="true"></iframe></noscript><div id="___gatsby"><div style="outline:none" tabindex="-1" id="gatsby-focus-wrapper"><div><div class="Header-module--header--3os44"><header aria-label="Site header"><ul class="SkipLinks-module--list--1WwLa" aria-label="Accessibility links"><li><a href="index.html#content-start" class="SkipLinks-module--link--hkZw8">Skip to content</a></li><li><a href="https://www.nice.org.uk/accessibility" class="SkipLinks-module--link--hkZw8">Accessibility help</a></li></ul><div class="Header-module--container--1mfIr"><a href="https://www.nice.org.uk/" aria-label="Home" class="Header-module--home--1TCPb"><svg viewBox="0 0 4616 512" fill="none" class="Header-module--icon--4LSt5" aria-hidden="true" focusable="false"><path d="M1626 44v175h-22L1497 71v148h-19V44h22l107 147V44h19zm130 154a52 52 0 01-47 23c-18 0-34-7-45-20a70 70 0 01-18-48c0-19 6-35 18-48 11-14 27-20 47-20 19 0 34 8 45 23V87h20v132h-20v-21zm-44 5c14 0 25-5 33-15 8-9 12-21 12-35s-4-26-12-35c-8-10-19-15-33-15s-25 5-34 15c-8 9-12 21-12 35s4 26 12 35c9 10 20 15 34 15zm109 16V104h-27V87h27V40h19v47h30v17h-30v115h-19zm88-180v26h-21V39h21zm-20 48h20v132h-20V87zm107-2c20 0 35 6 48 20 11 12 17 28 17 48 0 19-6 36-17 48a61 61 0 01-48 20c-19 0-35-7-47-20a69 69 0 01-17-48c0-20 5-36 17-48 12-14 28-20 47-20zm0 118c14 0 25-5 34-15 7-9 11-21 11-35s-4-26-11-35c-9-10-20-15-34-15s-25 5-33 15c-8 9-12 21-12 35s4 26 12 35c8 10 19 15 33 15zm107-116v21c5-7 11-12 18-17 6-4 14-6 23-6 8 0 16 1 22 4 6 2 12 6 17 11 10 10 16 24 16 42v77h-20v-76c0-13-3-22-10-29-7-8-16-11-26-11a38 38 0 00-40 40v76h-19V87h19zm222 111a52 52 0 01-46 23c-19 0-34-7-46-20a71 71 0 01-17-48c0-19 5-35 17-48 12-14 27-20 47-20 19 0 35 8 45 23V87h20v132h-20v-21zm-44 5c14 0 25-5 33-15 8-9 12-21 12-35s-4-26-12-35c-8-10-19-15-33-15s-25 5-34 15c-8 9-12 21-12 35s4 26 12 35c9 10 20 15 34 15zm114 16h-19V34h19v185zm108 0h-19V44h19v175zm55-132v21c5-7 10-12 17-17 7-4 15-6 23-6 9 0 17 1 23 4 6 2 12 6 16 11 11 10 16 24 16 42v77h-19v-76c0-13-4-22-10-29-7-8-16-11-27-11a38 38 0 00-39 40v76h-19V87h19zm202 35c-2-13-13-20-33-20s-30 6-30 19c0 5 2 9 6 12 5 2 10 5 16 6l21 5 21 7c7 2 12 6 16 11 5 5 7 11 7 19 0 13-5 23-15 30-9 7-22 10-38 10-18 0-32-4-42-13-9-8-14-18-15-31h20c2 13 8 21 21 25l13 2 13-1 11-3c8-3 12-9 12-17 0-5-2-9-6-12s-10-6-16-7l-21-5-21-7c-7-2-12-6-16-10-4-5-6-11-6-19 0-12 4-22 12-28 9-7 22-10 39-10 15 0 28 4 37 11 8 7 12 16 14 26h-20zm60 97V104h-26V87h26V40h20v47h30v17h-30v115h-20zm89-180v26h-21V39h21zm-21 48h20v132h-20V87zm65 132V104h-26V87h26V40h20v47h30v17h-30v115h-20zm162 0v-21c-4 7-10 12-17 16-7 5-14 7-23 7s-16-1-22-4c-7-2-12-6-17-11a57 57 0 01-16-42V87h20v76c0 12 3 22 10 29 6 7 15 11 26 11a39 39 0 0039-40V87h20v132h-20zm65 0V104h-26V87h26V40h20v47h30v17h-30v115h-20zm124-16c17 0 30-7 37-22h22c-5 12-12 22-22 29-9 7-22 11-38 11-19 0-35-7-47-20a68 68 0 01-18-48c0-20 5-36 17-48 12-14 28-20 47-20 20 0 35 6 48 20 11 12 17 28 17 48v8h-109c1 12 6 22 14 30s19 12 32 12zm-2-100c-12 0-22 4-30 11s-12 17-14 28h88c-1-11-6-21-14-28s-18-11-30-11zm195-52c-9 0-16 2-21 6-4 4-7 11-7 20v10h30v17h-30v115h-19V104h-23V87h23V75c0-14 4-25 12-32 9-7 21-11 36-11h1v19h-2zm75 34c19 0 35 6 47 20 12 12 18 28 18 48 0 19-6 36-18 48a61 61 0 01-47 20c-19 0-35-7-47-20a69 69 0 01-18-48c0-20 6-36 18-48 12-14 28-20 47-20zm0 118c14 0 25-5 33-15 8-9 12-21 12-35s-4-26-12-35c-8-10-19-15-33-15s-25 5-33 15c-8 9-12 21-12 35s4 26 12 35c8 10 19 15 33 15zm156-118v20h-2c-14 0-25 5-34 17-9 11-13 24-13 39v58h-19V87h19v32c4-13 13-23 27-30 6-3 13-4 21-4h1zM1617 293v175h-19v-78h-101v78h-19V293h19v78h101v-78h19zm91 159c18 0 30-8 38-22h21c-4 12-11 21-21 29-10 7-23 11-38 11-20 0-36-7-48-20a68 68 0 01-18-48c0-20 6-36 17-49 12-13 28-19 48-19 19 0 35 6 47 19 11 13 17 29 17 49v8h-109c1 12 6 22 14 30 9 8 19 12 32 12zm-1-100c-12 0-22 3-31 11-7 7-12 17-14 28h89c-2-11-7-21-14-28-8-8-18-11-30-11zm187 95a52 52 0 01-47 23c-18 0-34-7-45-20a70 70 0 01-18-48c0-19 6-36 18-49 11-13 27-19 47-19 19 0 34 7 45 23v-21h20v132h-20v-21zm-44 5c14 0 25-5 33-15 8-9 12-21 12-35 0-15-4-26-12-36s-19-14-33-14-25 4-34 14c-8 10-12 21-12 36 0 14 4 26 12 35 9 10 20 15 34 15zm114 16h-19V283h19v185zm46 0V353h-27v-17h27v-48h19v48h30v17h-30v115h-19zm87-185v73l17-16c7-4 15-6 24-6 8 0 16 1 22 3a58 58 0 0133 54v77h-20v-77c0-12-3-21-10-29-7-7-16-10-26-10a39 39 0 00-40 40v76h-19V283h19zm280 164a52 52 0 01-47 23c-19 0-34-7-46-20a70 70 0 01-17-48c0-19 6-36 17-49 12-13 28-19 47-19 20 0 35 7 46 23v-21h19v132h-19v-21zm-44 5c14 0 25-5 33-15 8-9 12-21 12-35 0-15-4-26-12-36s-19-14-33-14-25 4-34 14c-8 10-12 21-12 36 0 14 4 26 12 35 9 10 20 15 34 15zm109-116v20c5-6 10-11 17-16 7-4 15-6 23-6 9 0 17 1 23 3 6 3 11 6 16 11 11 11 16 25 16 43v77h-19v-77c0-12-4-21-10-29-7-7-16-10-27-10a39 39 0 00-39 40v76h-19V336h19zm222 111a52 52 0 01-47 23c-19 0-34-7-46-20a71 71 0 01-17-48c0-19 6-36 17-49 12-13 28-19 47-19 20 0 35 7 46 23v-74h19v185h-19v-21zm-44 5c14 0 25-5 33-15 8-9 12-21 12-35 0-15-4-26-12-36s-19-14-33-14-25 4-34 14c-8 10-12 21-12 36 0 14 4 26 12 35 9 10 20 15 34 15zm233-1a56 56 0 0053-36h21c-6 17-15 30-28 39a82 82 0 01-50 16c-25 0-46-9-61-26a92 92 0 01-22-64c0-25 7-46 22-63 15-18 36-26 61-26a78 78 0 0178 54h-21c-4-11-11-19-20-25-10-7-20-10-33-10-12 0-22 2-30 5-9 4-15 9-21 15a73 73 0 00-17 50c0 21 6 37 17 50 12 14 29 21 51 21zm198-4a52 52 0 01-47 23c-19 0-34-7-46-20a70 70 0 01-17-48c0-19 6-36 17-49 12-13 28-19 48-19 19 0 34 7 45 23v-21h19v132h-19v-21zm-44 5c14 0 25-5 33-15 8-9 12-21 12-35 0-15-4-26-12-36s-19-14-33-14-25 4-34 14c-8 10-12 21-12 36 0 14 4 26 12 35 9 10 20 15 34 15zm163-118v19h-2c-14 0-26 6-34 18-9 10-13 23-13 39v58h-19V336h19v32c4-14 13-24 27-30 6-3 13-4 21-4h1zm73 118c18 0 31-8 38-22h21c-4 12-11 21-21 29-10 7-22 11-38 11-19 0-35-7-48-20a68 68 0 01-18-48c0-20 6-36 18-49s27-19 47-19c19 0 35 6 47 19s17 29 17 49v8h-109c2 12 7 22 15 30s19 12 31 12zm-1-100c-12 0-22 3-30 11-8 7-13 17-14 28h88c-2-11-6-21-14-28-8-8-18-11-30-11zm162-40v59h96v19h-96v59h108v19h-127V293h127v19h-108zm189 88l51 68h-25l-37-54-37 54h-25l51-68-48-64h25l34 50 33-50h25l-47 64zm120 52c9 0 16-3 23-7 6-5 11-11 14-19h21c-4 13-12 24-22 32-11 8-24 12-40 12-19 0-34-7-46-20a69 69 0 01-18-48c0-20 6-36 18-49s27-19 46-19a60 60 0 0161 44h-20c-3-8-8-15-14-19-7-5-14-7-23-7-8 0-15 1-21 4-6 2-10 6-14 10-9 10-13 22-13 36s4 26 13 35c8 10 20 15 35 15zm137 0c18 0 30-8 38-22h21c-4 12-11 21-21 29-10 7-22 11-38 11-20 0-35-7-48-20a68 68 0 01-18-48c0-20 6-36 17-49 13-13 28-19 48-19 19 0 35 6 47 19s17 29 17 49v8h-109c2 12 6 22 15 30 8 8 19 12 31 12zm-1-100c-12 0-22 3-30 11-8 7-13 17-14 28h88c-2-11-6-21-14-28-8-8-18-11-30-11zm105 116h-19V283h19v185zm51 0h-20V283h20v185zm89-16c18 0 30-8 38-22h21c-4 12-11 21-21 29-10 7-23 11-38 11-20 0-36-7-48-20a68 68 0 01-18-48c0-20 6-36 17-49 12-13 28-19 48-19 19 0 35 6 47 19 11 13 17 29 17 49v8h-109c2 12 6 22 14 30 9 8 19 12 32 12zm-1-100c-12 0-22 3-31 11-7 7-12 17-14 28h89c-2-11-7-21-14-28-8-8-18-11-30-11zm105-16v20c5-6 10-11 17-16 7-4 15-6 23-6 9 0 17 1 23 3 6 3 12 6 16 11 11 11 16 25 16 43v77h-19v-77c0-12-4-21-10-29-7-7-16-10-27-10s-20 3-28 11c-7 7-11 17-11 29v76h-19V336h19zm185 116a40 40 0 0037-26h21c-4 13-12 24-22 32-11 8-25 12-40 12-19 0-34-7-46-20a69 69 0 01-18-48c0-20 6-36 18-49s27-19 46-19c15 0 29 4 40 12 10 8 18 18 22 31h-21c-3-7-8-14-15-18-6-5-13-7-22-7-8 0-15 1-21 4-6 2-11 6-15 10-8 10-12 22-12 36s4 26 12 35c9 10 21 15 36 15zm137 0c18 0 30-8 38-22h21c-4 12-11 21-21 29-10 7-23 11-38 11-20 0-36-7-48-20a68 68 0 01-18-48c0-20 6-36 17-49 12-13 28-19 48-19 19 0 35 6 47 19s17 29 17 49v8h-109c2 12 6 22 15 30 8 8 18 12 31 12zm-1-100c-12 0-22 3-30 11-8 7-13 17-15 28h89c-2-11-6-21-14-28-8-8-18-11-30-11zM412 454c0 16-7 19-18 19h-53c-11 0-20-4-27-13L130 213h-2v242c0 13-6 18-18 18H52c-14 0-20-3-20-18V62c0-16 7-19 20-19h52c13 0 19 3 26 13l184 248h1V61c0-14 7-18 19-18h60c16 0 17 8 17 19v392h1zm197 4c0 7-5 14-14 14h-71c-9 0-14-7-14-14V56c0-8 5-15 14-15h71c9 0 14 7 14 14v403zm415-380l-18 52c-2 6-5 9-9 9l-8-2c-33-16-58-21-87-21-65 0-106 49-106 140 0 98 47 140 107 140 29 0 55-5 84-17l9-3c6 0 9 3 11 10l16 46 2 10c0 6-3 11-12 14-42 16-77 24-125 24-131 0-197-87-197-221S772 32 896 32c45 0 82 9 118 25 9 4 12 8 12 12l-2 9zm336-37c13 0 17 6 16 15l-6 50c-1 13-9 15-24 15h-149v93h140c14 0 19 7 19 17v45c0 12-7 18-18 18h-141v98h161c11 0 18 5 18 17v46c0 11-6 17-17 17h-240c-14 0-21-4-21-19V59c0-11 6-18 16-18h246z" fill="currentColor"></path></svg></a><div class="Header-module--wrapper--2e13D"><div class="Header-module--search--2nfnz"><form id="global-nav-search-form" role="search" action="https://cks.nice.org.uk/search" class="Search-module--search--2wNll"><label class="Search-module--label--1rrog" for="autocomplete">Search CKS…</label><div class="Autocomplete-module--ac--2PqiF"><div class="autocomplete__wrapper"><input type="search" id="autocomplete" name="q" class="autocomplete__input autocomplete__input--default" placeholder="Search CKS…" data-hj-allow="" maxLength="512" value=""/></div></div><button class="Search-module--button--2FbnI" type="submit" aria-label="Perform search"><svg width="1em" height="1em" viewBox="0 0 512 512" fill="none" class="Search-module--icon--2JB42" aria-hidden="true" focusable="false"><path d="M83.784 476.472L197.112 363.16c30.144 20.32 65.056 30.528 100.032 30.528 45.904 0 91.776-17.488 126.8-52.528 70.064-70.064 70.064-183.584 0-253.616C388.936 52.504 343.048 35 297.144 35c-45.904 0-91.808 17.504-126.848 52.528-61.696 61.696-68.976 157.12-21.968 226.864L35 427.752l48.784 48.72zm213.36-137.952c-33.168 0-64.352-12.896-87.792-36.368-48.416-48.448-48.416-127.2 0-175.616 23.44-23.44 54.64-36.352 87.792-36.352s64.336 12.912 87.776 36.368c23.44 23.456 36.384 54.64 36.384 87.792s-12.928 64.352-36.384 87.792c-23.456 23.472-54.624 36.368-87.776 36.368v.016z" fill="currentColor"></path></svg></button></form></div><button class="Header-module--mobileMenuBtn--1LgyL" id="header-menu-button" type="button" aria-controls="header-menu" aria-expanded="false" aria-haspopup="menu" aria-label="Expand site menu">Menu</button></div></div><div id="header-menu" class="Nav-module--wrapper--2_xng Nav-module--wrapperWithSubLinks--3PUfX"><nav class="Nav-module--nav--2aQpa" aria-label="primary navigation"><div class="Nav-module--menuWrapper--2fp8S"><ul class="Nav-module--menuList--264L-" aria-labelledby="header-menu-button"><li><a href="https://pathways.nice.org.uk/" class="Nav-module--link--3JzDA">NICE Pathways</a></li><li><a href="https://www.nice.org.uk/guidance" class="Nav-module--link--3JzDA">NICE guidance</a></li><li><a href="https://www.nice.org.uk/standards-and-indicators" class="Nav-module--link--3JzDA">Standards and indicators</a></li><li><a href="https://www.evidence.nhs.uk/" class="Nav-module--link--3JzDA">Evidence search</a></li><li><a href="https://bnf.nice.org.uk/" class="Nav-module--link--3JzDA"><abbr title="British National Formulary">BNF<!-- --> <span class="Nav-module--visuallyHidden--ORHqX">British National Formulary</span></abbr><span aria-hidden="true" class="Nav-module--tooltip--1Uj-W">British National Formulary</span></a></li><li><a href="https://bnfc.nice.org.uk/" class="Nav-module--link--3JzDA"><abbr title="British National Formulary for Children">BNFC<!-- --> <span class="Nav-module--visuallyHidden--ORHqX">British National Formulary for Children</span></abbr><span aria-hidden="true" class="Nav-module--tooltip--1Uj-W">British National Formulary for Children</span></a></li><li><a href="../../../../index.html" aria-current="true" class="Nav-module--link--3JzDA"><abbr title="Clinical Knowledge Summaries">CKS<!-- --> <span class="Nav-module--visuallyHidden--ORHqX">Clinical Knowledge Summaries</span></abbr><span aria-hidden="true" class="Nav-module--tooltip--1Uj-W">Clinical Knowledge Summaries</span></a><div class="SubNav-module--wrapper--yAXWY"><ul class="SubNav-module--list--1K9bK" aria-label="CKS links"><li class="SubNav-module--imageLink--3xwIS"><a href="../../../../index.html" class="SubNav-module--link--39i23" aria-label="CKS - Home"><img src="data:image/svg+xml;base64,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" class="SubNav-module--image--uq-a2" alt=""/></a></li><li><a href="../../../index.html" class="SubNav-module--link--39i23" aria-label="Health topics A to Z">Health topics A to Z</a></li><li><a href="../../../../specialities/index.html" class="SubNav-module--link--39i23" aria-label="Specialities">Specialities</a></li><li><a href="../../../../whats-new/index.html" class="SubNav-module--link--39i23" aria-label="What&#x27;s new">What&#x27;s new</a></li><li><a href="../../../../about/index.html" class="SubNav-module--link--39i23" aria-label="About CKS">About CKS</a></li></ul></div></li><li><a href="https://www.nice.org.uk/about/what-we-do/evidence-services/journals-and-databases" class="Nav-module--link--3JzDA">Journals and databases</a></li></ul></div></nav></div></header><aside class="CoronaMessage-module--wrapper--zRiaV" aria-label="COVID-19 Notice"><div class="CoronaMessage-module--container--36Biz"><p>Read about<!-- --> <a href="https://www.nice.org.uk/covid-19">our approach to COVID-19</a></p></div></aside></div></div><main class="Layout-module--main--1OIFf" id="content-start"><div class="container"><nav aria-label="Breadcrumbs" role="navigation"><ol class="breadcrumbs"><li class="breadcrumbs__crumb"><a href="https://www.nice.org.uk/">NICE</a></li><li class="breadcrumbs__crumb"><a href="../../../../index.html">CKS</a></li><li class="breadcrumbs__crumb"><a href="../../../index.html">Health topics A to Z</a></li><li class="breadcrumbs__crumb"><a href="../../index.html">Diarrhoea - prevention and advice for travellers</a></li><li class="breadcrumbs__crumb"><a href="../index.html">Management</a></li><li class="breadcrumbs__crumb"><span>Scenario: Diarrhoea - prevention and advice for travellers</span></li></ol></nav><script type="application/ld+json">{"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"https://www.nice.org.uk/","name":"NICE"}},{"@type":"ListItem","position":2,"item":{"@id":"/","name":"CKS"}},{"@type":"ListItem","position":3,"item":{"@id":"/topics/","name":"Health topics A to Z"}},{"@type":"ListItem","position":4,"item":{"@id":"/topics/diarrhoea-prevention-advice-for-travellers/","name":"Diarrhoea - prevention and advice for travellers"}},{"@type":"ListItem","position":5,"item":{"@id":"/topics/diarrhoea-prevention-advice-for-travellers/management/","name":"Management"}},{"@type":"ListItem","position":6,"item":{"name":"Scenario: Diarrhoea - prevention and advice for travellers"}}]}</script><div class="page-header"><h1 class="page-header__heading"><span class="page-header__pre-heading">Diarrhoea - prevention and advice for travellers: </span><span>Scenario: Diarrhoea - prevention and advice for travellers</span></h1><p class="page-header__lead"><span>Last revised in February 2019</span></p></div><p class="visually-hidden">Covers the prevention of travellers&#x27; diarrhoea, and advice for people who are at risk of travellers&#x27; diarrhoea.</p><div class="ChapterContents-module--wrapper--3ONbu"><div class="ChapterContents-module--menu--3Epka"><nav class="stacked-nav" aria-label="Diarrhoea - prevention and advice for travellers chapters"><ul class="stacked-nav__list"><li class="stacked-nav__list-item" data-tracking="Summary"><a aria-current="false" href="../../index.html"><span class="stacked-nav__content-wrapper">Summary</span></a></li><li class="stacked-nav__list-item" data-tracking="Have I got the right topic?"><a aria-current="false" href="../../have-i-got-the-right-topic/index.html"><span class="stacked-nav__content-wrapper">Have I got the right topic?</span></a></li><li class="stacked-nav__list-item" data-tracking="How up-to-date is this topic?"><a aria-current="false" href="../../how-up-to-date-is-this-topic/index.html"><span class="stacked-nav__content-wrapper">How up-to-date is this topic?</span></a></li><li class="stacked-nav__list-item" data-tracking="Goals and outcome measures"><a aria-current="false" href="../../goals-outcome-measures/index.html"><span class="stacked-nav__content-wrapper">Goals and outcome measures</span></a></li><li class="stacked-nav__list-item" data-tracking="Background information"><a aria-current="false" href="../../background-information/index.html"><span class="stacked-nav__content-wrapper">Background information</span></a></li><li class="stacked-nav__list-item" data-tracking="Management"><a aria-current="false" href="../index.html"><span class="stacked-nav__content-wrapper">Management</span></a><ul class="stacked-nav__nested"><li class="stacked-nav__list-item" data-tracking="Management | Scenario: Diarrhoea - prevention and advice for travellers"><a aria-current="true" class="" href="index.html"><span class="stacked-nav__content-wrapper">Scenario: Diarrhoea - prevention and advice for travellers</span></a></li></ul></li><li class="stacked-nav__list-item" data-tracking="Supporting evidence"><a aria-current="false" href="../../supporting-evidence/index.html"><span class="stacked-nav__content-wrapper">Supporting evidence</span></a></li><li class="stacked-nav__list-item" data-tracking="How this topic was developed"><a aria-current="false" href="../../how-this-topic-was-developed/index.html"><span class="stacked-nav__content-wrapper">How this topic was developed</span></a></li><li class="stacked-nav__list-item" data-tracking="References"><a aria-current="false" href="../../references/index.html"><span class="stacked-nav__content-wrapper">References</span></a></li></ul></nav></div><div class="ChapterContents-module--onThisPage--1333P"><nav class="ChapterOnThisPage-module--wrapper--2zc7n" aria-labelledby="on-this-page"><h2 class="ChapterOnThisPage-module--heading--2SdDN" id="on-this-page">On this page</h2><ol class="ChapterOnThisPage-module--rootList--2II70" aria-label="Jump links to section on this page"><li><a href="index.html#assessing-risk-before-travelling">Assessing risk (before travelling)</a><ol aria-label="Sections within Assessing risk (before travelling)" class="ChapterOnThisPage-module--subList--Pwxy9 "><li class="ChapterOnThisPage-module--basisForRecs--1xLSs"><a href="index.html#basis-for-recommendation-ca7">Basis for recommendation</a></li></ol></li><li><a href="index.html#managing-people-at-low-or-intermediate-risk">Managing people at low or intermediate risk</a><ol aria-label="Sections within Managing people at low or intermediate risk" class="ChapterOnThisPage-module--subList--Pwxy9 "><li class="ChapterOnThisPage-module--basisForRecs--1xLSs"><a href="index.html#basis-for-recommendation-599">Basis for recommendation</a></li></ol></li><li><a href="index.html#managing-people-at-high-risk">Managing people at high risk</a><ol aria-label="Sections within Managing people at high risk" class="ChapterOnThisPage-module--subList--Pwxy9 "><li class="ChapterOnThisPage-module--basisForRecs--1xLSs"><a href="index.html#basis-for-recommendation-72d">Basis for recommendation</a></li></ol></li><li><a href="index.html#advice-on-food-drink">Advice on food and drink</a><ol aria-label="Sections within Advice on food and drink" class="ChapterOnThisPage-module--subList--Pwxy9 "><li class="ChapterOnThisPage-module--basisForRecs--1xLSs"><a href="index.html#basis-for-recommendation-b89">Basis for recommendation</a></li></ol></li><li><a href="index.html#advice-on-managing-travellers-diarrhoea">Advice on managing travellers&#x27; diarrhoea</a><ol aria-label="Sections within Advice on managing travellers&#x27; diarrhoea" class="ChapterOnThisPage-module--subList--Pwxy9 "><li class="ChapterOnThisPage-module--basisForRecs--1xLSs"><a href="index.html#basis-for-recommendation-79c">Basis for recommendation</a></li></ol></li><li><a href="index.html#prophylactic-antibiotic-treatment-for-travellers-diarrhoea">Prophylactic antibiotic treatment for travellers&#x27; diarrhoea</a><ol aria-label="Sections within Prophylactic antibiotic treatment for travellers&#x27; diarrhoea" class="ChapterOnThisPage-module--subList--Pwxy9 "><li class="ChapterOnThisPage-module--basisForRecs--1xLSs"><a href="index.html#basis-for-recommendation-1c7">Basis for recommendation</a></li></ol></li><li><a href="index.html#stand-by-antibiotic-treatment-for-travellers-diarrhoea">&#x27;Stand-by&#x27; antibiotic treatment for travellers&#x27; diarrhoea</a><ol aria-label="Sections within &#x27;Stand-by&#x27; antibiotic treatment for travellers&#x27; diarrhoea" class="ChapterOnThisPage-module--subList--Pwxy9 "><li class="ChapterOnThisPage-module--basisForRecs--1xLSs"><a href="index.html#basis-for-recommendation-ba9">Basis for recommendation</a></li></ol></li></ol></nav></div><div class="ChapterContents-module--body--1XBoo"><section aria-labelledby="diarrhoea-prevention-advice-for-travellers" class="ChapterBody-module--wrapper--2HCfk "><h2 id="diarrhoea-prevention-advice-for-travellers" class="visually-hidden">Scenario: Diarrhoea - prevention and advice for travellers</h2><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item 08c1d696-7360-4515-a1b2-4ed7d84b6c0c --><!-- begin field c8fb26a8-dae2-4ed8-b603-acbd00883375 --><p>From age 1 month onwards.</p><!-- end field c8fb26a8-dae2-4ed8-b603-acbd00883375 --><!-- end item 08c1d696-7360-4515-a1b2-4ed7d84b6c0c --></div><section aria-labelledby="assessing-risk-before-travelling" class="ChapterBody-module--wrapper--2HCfk "><h3 id="assessing-risk-before-travelling">How should I assess the risk of acquiring travellers' diarrhoea before travelling?</h3><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item 453b0c98-8cfe-493d-bf9e-65f93c1c1560 --><!-- begin field 5b5867e5-9609-4635-b8a0-ce4f5551defa --><ul><li><strong>Ask which country the person is going to visit</strong>.<ul><li>Low risk areas (fewer than 7% of travellers experience travellers' diarrhoea) include western Europe, USA, Canada, Japan, Australia, and New Zealand. </li><li>Intermediate risk areas (8–20% of travellers experience travellers' diarrhoea) include southern Europe, Israel, South Africa, and some Caribbean and Pacific islands.</li><li>High risk areas (more than 20% of travellers experience travellers' diarrhoea) include Africa, Latin America, the Middle East, and most parts of Asia. </li></ul></li><li><strong>For assessment of individual countries where travellers should practice strict food, water, and personal hygiene precautions</strong>, see the National Travel Health Network and Centre (NaTHNaC) website (<a data-hyperlink-id="ced44047-1247-44e8-aa3f-a93100a238a0" href="http://www.nathnac.org/ds/map_world.aspx">www.nathnac.org</a>). </li><li><strong>Assess for other risk factors known to further increase the risk of travellers' diarrhoea such as: </strong><ul><li>Local amenities and sanitation — in areas with low standards of hygiene and sanitation and poor control over the safety of food, drink, and drinking water, the risk of acquiring travellers' diarrhoea is high. </li><li>How the person will be travelling — backpackers, campers, adventurers, and passengers on cruise ships are at increased risk.</li><li>When the person will be travelling — the peak incidence of travellers' diarrhoea is in the warmer months. Lower rates occur in winter.</li><li>What the person eats — for example risks are associated with food from buffets, restaurants, and street vendors, and certain types of food such as raw fish and seafood, salads, and meat and poultry that has been inadequately cooked. For more information, see <a class="topic-reference internal-reference" href="index.html#advice-on-food-drink">Advice on food and drink</a>. </li></ul></li><li><strong>Review the person's susceptibility to traveller's diarrhoea and their risk of complications. </strong>For more information on which groups of people are considered to be at higher risk, see the section on <a class="topic-reference internal-reference" href="../../background-information/risk-factors/index.html">Risk factors</a>. </li><li><strong>Enquire about access to medical amenities </strong>— this is particularly important for those travelling to remote areas with few or no medical amenities (especially trekking, camping).</li><li><strong>Discuss whether journeys to high-risk areas are essential </strong>and whether the person is suitably prepared (for example if backpacking through remote areas).</li></ul><!-- end field 5b5867e5-9609-4635-b8a0-ce4f5551defa --><!-- end item 453b0c98-8cfe-493d-bf9e-65f93c1c1560 --></div><section aria-labelledby="basis-for-recommendation-ca7" class="ChapterBody-module--wrapper--2HCfk "><h4 id="basis-for-recommendation-ca7">Basis for recommendation</h4><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item ca773f15-8985-43f4-b777-ad81119f2c1d --><!-- begin field 9a83cae5-b3d7-475d-90f1-a2ec48921757 --><h5>Assessing risk of travellers' diarrhoea</h5><ul><li>The recommendation to perform a pre-travel assessment is based on advice from the World Health Organization (WHO) which suggests medical advisers base their recommendations on an assessment of risk for the individual person, considering features such as the likelihood of acquiring a disease and the potential consequences for the person. Examples include the destination, standards of accomodation and food hygiene, mode of transport, pretravel health status, and purpose of travel [<a class="bibliography-reference internal-reference" href="../../references/index.html">WHO, 2012</a>].  </li></ul><h5>Destination</h5><ul><li>The travel destination is regarded as an important determinant of risk for travellers' diarrhoea [<a class="bibliography-reference internal-reference" href="../../references/index.html">CATMAT, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">CDC, 2017a</a>]. Countries and places with generally poor standards of hygiene pose a greater risk. Although the risks are greater in developing countries, locations with poor hygiene may be present in any country [<a class="bibliography-reference internal-reference" href="../../references/index.html">WHO, 2012</a>].  </li><li>The examples of low, intermediate, and high-risk areas of travel are based on information from the National Travel Health Network and Centre (NaTHNaC) [<a class="bibliography-reference internal-reference" href="../../references/index.html">NaTHNaC, 2016</a>]. </li></ul><h5>Other risk factors associated with the destination of travel</h5><ul><li>The recommendation to assess for other risk factors is extrapolated from information published by the WHO [<a class="bibliography-reference internal-reference" href="../../references/index.html">WHO, 2012</a>]<strong> </strong>and a Canadian advisory committee statement on traveller's diarrhoea [<a class="bibliography-reference internal-reference" href="../../references/index.html">CATMAT, 2015</a>], as well as expert opinion in review articles [<a class="bibliography-reference internal-reference" href="../../references/index.html">Leder, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Steffen, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Barrett, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Giddings et al, 2016</a>].  </li></ul><h5>Susceptibility to travellers' diarrhoea and risk of complications</h5><ul><li>A number of guidelines and experts discuss people who are at more risk of developing travellers' diarrhoea or experiencing adverse consequences. CKS has extrapolated this recommendation from these sources [<a class="bibliography-reference internal-reference" href="../../references/index.html">CATMAT, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Steffen, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Barrett, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">NaTHNaC, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Barrett and Brown, 2018</a>]. </li></ul><h5>Access to medical amenities</h5><ul><li>Some travellers may have difficulty accessing reliable medical care [<a class="bibliography-reference internal-reference" href="../../references/index.html">WHO, 2012</a>].  Whether the person has access to appropriate medical care will influence the decision whether to provide the person with 'stand-by' treatment for travellers' diarrhoea [<a class="bibliography-reference internal-reference" href="../../references/index.html">Giddings et al, 2016</a>].  </li></ul><h5>Importance of journeys to high risk areas</h5><ul><li>This recommendation is pragmatic and based on what CKS considers to be good practice.</li></ul><!-- end field 9a83cae5-b3d7-475d-90f1-a2ec48921757 --><!-- end item ca773f15-8985-43f4-b777-ad81119f2c1d --></div></section></section><section aria-labelledby="managing-people-at-low-or-intermediate-risk" class="ChapterBody-module--wrapper--2HCfk "><h3 id="managing-people-at-low-or-intermediate-risk">How should I manage someone at low or intermediate risk of travellers' diarrhoea?</h3><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item 67211376-df4d-42a5-a7c0-646e43503abe --><!-- begin field 971377b6-44a0-47a8-8742-14275a76945d --><ul><li><strong>For people at <a class="topic-reference internal-reference" href="index.html#assessing-risk-before-travelling">low or intermediate risk</a> of travellers' diarrhoea:</strong><ul><li>Advise the person that most travellers' diarrhoea is caused by the consumption of contaminated food or water.</li><li>Reassure the person that no special precautions (other than basic hygiene measures) are required when travelling to locations with a high standard of hygiene.</li><li>Provide information on <a class="topic-reference internal-reference" href="index.html#advice-on-food-drink">food hygiene and safe drinking water</a> if the person is travelling to locations with low standards of hygiene and sanitation.</li><li>Offer advice regarding <a class="topic-reference internal-reference" href="index.html#advice-on-managing-travellers-diarrhoea">self-management</a> and when to seek medical advice if the person develops diarrhoea during their trip.</li></ul></li></ul><!-- end field 971377b6-44a0-47a8-8742-14275a76945d --><!-- end item 67211376-df4d-42a5-a7c0-646e43503abe --></div><section aria-labelledby="basis-for-recommendation-599" class="ChapterBody-module--wrapper--2HCfk "><h4 id="basis-for-recommendation-599">Basis for recommendation</h4><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item 5997e934-0e1a-4987-98fa-e76350faae6d --><!-- begin field c7d7c70d-7ac0-4291-83cb-a2bca1ac76c2 --><ul><li>These recommendations reflect general advice issued to travellers by the UK National Travel Health Network and Centre [<a class="bibliography-reference internal-reference" href="../../references/index.html">NaTHNaC, 2016</a>] US guidelines and a Canadian advisory committee statement [<a class="bibliography-reference internal-reference" href="../../references/index.html">CATMAT, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>], information from the Centers for Disease Control and Prevention [<a class="bibliography-reference internal-reference" href="../../references/index.html">CDC, 2017a</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">CDC, 2017b</a>], and expert opinion in review articles [<a class="bibliography-reference internal-reference" href="../../references/index.html">Leder, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Steffen, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Giddings et al, 2016</a>].  </li><li>Although the risks of travellers' diarrhoea are greater in developing countries, all travellers should be reminded of basic hygiene measures because locations with poor hygiene may be present in any country [<a class="bibliography-reference internal-reference" href="../../references/index.html">WHO, 2012</a>]. </li></ul><!-- end field c7d7c70d-7ac0-4291-83cb-a2bca1ac76c2 --><!-- end item 5997e934-0e1a-4987-98fa-e76350faae6d --></div></section></section><section aria-labelledby="managing-people-at-high-risk" class="ChapterBody-module--wrapper--2HCfk "><h3 id="managing-people-at-high-risk">How should I manage someone at high risk of travellers' diarrhoea?</h3><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item e9d2d9b2-e3ee-4c04-8415-8e4b34056bb5 --><!-- begin field 53a6e17a-43a6-4b5c-b988-26eb49cde83d --><ul><li><strong>For people at <a class="topic-reference internal-reference" href="index.html#assessing-risk-before-travelling">high risk</a>:</strong><ul><li><strong>Emphasize the importance of personal hygiene, as well as food hygiene and safe drinking water, to reduce the risk of travellers' diarrhoea.</strong><ul><li>For further information, see <a class="topic-reference internal-reference" href="index.html#advice-on-food-drink">advice on food and drink</a>.</li></ul></li><li><strong>Warn travellers about the risk of food- and water-borne infections and how to avoid potentially contaminated recreational water. </strong>Contaminated recreational water can be found in inadequately treated pools, water playgrounds, hot tubs, spas, and freshwater or sea water. Potential illness-causing contaminants include human faeces, animal waste, sewage, or wastewater runoff.</li><li><strong>Do not routinely offer prophylactic treatment for prevention of travellers' diarrhoea, as it is not indicated for most travellers.</strong><ul><li>Antibiotic prophylaxis may be appropriate for certain high-risk travellers. For more information, see the section on <a class="topic-reference internal-reference" href="index.html#prophylactic-antibiotic-treatment-for-travellers-diarrhoea">prophylactic antibiotics</a>.</li><li>The use of bismuth subsalicylate and probiotics for prophylaxis is not recommended.</li><li>Antidiarrhoeal drugs (such as loperamide) should not be taken prophylactically.</li></ul></li><li><strong>Consider whether 'stand by' antibiotic treatment (to use if affected) is appropriate. </strong>For more information, see the section on <a class="topic-reference internal-reference" href="index.html#stand-by-antibiotic-treatment-for-travellers-diarrhoea">&#39;stand-by&#39; antibiotics</a>.</li><li><strong>Inform the person that there are no universal vaccines to cover all the infections which may cause travellers' diarrhoea. </strong>However, travellers to risky areas must seek advice about appropriate vaccination against other intestinal infections such as cholera, hepatitis A, and typhoid. For further information on vaccines recommended for overseas travel and extended holidays, or for people working overseas, see the CKS topic on <a class="topic-reference external-reference" href="../../../immunizations-travel/index.html">Immunizations - travel</a>.</li><li><strong>Offer advice regarding self-management and when to seek medical advice if the person develops diarrhoea during their trip.</strong><ul><li>For further information, see <a class="topic-reference internal-reference" href="index.html#advice-on-managing-travellers-diarrhoea">advice on managing travellers&#39; diarrhoea</a>.</li></ul></li></ul></li></ul><!-- end field 53a6e17a-43a6-4b5c-b988-26eb49cde83d --><!-- end item e9d2d9b2-e3ee-4c04-8415-8e4b34056bb5 --></div><section aria-labelledby="basis-for-recommendation-72d" class="ChapterBody-module--wrapper--2HCfk "><h4 id="basis-for-recommendation-72d">Basis for recommendation</h4><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item 72de8ce4-ab72-49b1-94ee-e9e5849774b2 --><!-- begin field e7463c4e-4ca2-4364-9faa-10d451b77dc9 --><p><strong>Personal and food hygiene, safe drinking water, and avoiding potentially contaminated recreational water.</strong></p><ul><li>These recommendations are based on information from the UK National Travel Health Network and Centre (NaTHNac) [<a class="bibliography-reference internal-reference" href="../../references/index.html">NaTHNaC, 2016</a>]; the World Health Organization (WHO) [<a class="bibliography-reference internal-reference" href="../../references/index.html">WHO, 2012</a>]; US guidance and information issued by the Centers for Disease Control and Prevention [<a class="bibliography-reference internal-reference" href="../../references/index.html">CDC, 2017b</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">CDC, 2017a</a>], the American College of Gastroenterology [<a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2016</a>],<strong> </strong>the Infectious Diseases Society of America [<a class="bibliography-reference internal-reference" href="../../references/index.html">Shane, 2017</a>]; and guidance from an advisory committee to the Public Health Agency of Canada [<a class="bibliography-reference internal-reference" href="../../references/index.html">CATMAT, 2015</a>]. </li></ul><h5>Prophylactic treatments</h5><ul><li>Apart from the use of prophylactic antibiotics for certain at-risk groups, the WHO does not recommend any particular measures for the prophylaxis of travellers' diarrhoea [<a class="bibliography-reference internal-reference" href="../../references/index.html">WHO, 2012</a>]. </li><li>Prophylactic antibiotics are not recommended for most travellers because they do not protect against nonbacterial pathogens, are associated with allergic and adverse reactions, and may contribute to drug resistance [<a class="bibliography-reference internal-reference" href="../../references/index.html">NaTHNaC, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">CDC, 2017b</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>]. </li><li>A number of organisations and experts suggest that bismuth subsalicylate may be considered as an option for the prevention of travellers' diarrhoea [<a class="bibliography-reference internal-reference" href="../../references/index.html">CATMAT, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Taylor et al, 2017</a>]. However, although bismuth subsalicylate is mentioned for prevention of travellers' diarrhoea in its summary of antimicrobial prescribing guidance, Public Health England states that ‘prophylaxis is rarely if ever indicated’ [<a class="bibliography-reference internal-reference" href="../../references/index.html">NICE and PHE, 2018</a>]<strong> </strong>and the US Centers for Disease Control and Prevention note that bismuth subsalicylate is not commonly used as prophylaxis for travellers' diarrhoea [<a class="bibliography-reference internal-reference" href="../../references/index.html">CDC, 2017a</a>]. Bismuth subsalicylate is also off-label for the prophylaxis of travellers' diarrhoea [<a class="bibliography-reference internal-reference" href="../../references/index.html">ABPI, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">MHRA, 2019</a>]. CKS has not recommended the primary care intiation of bismuth subsalicylate for prophylaxis taking this into account, in addition to feedback from previous expert reviewers of this CKS topic and other factors limiting the usefulness of bismuth subsalicylate as a prophylactic treatment, for example: <ul><li>Compliance may be difficult as the treatment needs to be taken four times a day [<a class="bibliography-reference internal-reference" href="../../references/index.html">CATMAT, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Giddings et al, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Taylor et al, 2017</a>]. </li><li>Prophylaxis is recommended for up to 3 weeks (based on duration of trials) [<a class="bibliography-reference internal-reference" href="../../references/index.html">CATMAT, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">CDC, 2017a</a>] and the quantity required might be inconvenient [<a class="bibliography-reference internal-reference" href="../../references/index.html">CDC, 2017a</a>]. </li><li>People may find the adverse effects unpleasant, particularly black tongue and stool, constipation, nausea, and tinnitus [<a class="bibliography-reference internal-reference" href="../../references/index.html">CDC, 2017a</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>].  </li><li>It is not suitable for people with aspirin or salicylate allergy, renal insufficiency, gout, or those who are taking an anticoagulant such as warfarin, or pregnant or breastfeeding women [<a class="bibliography-reference internal-reference" href="../../references/index.html">ABPI, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">MHRA, 2019</a>]. </li><li>There is potential for drug interactions, including bismuth subsalicylate reducing absorption of doxycycline which may also be required for malaria prophylaxis [<a class="bibliography-reference internal-reference" href="../../references/index.html">Giddings et al, 2016</a>].  </li><li>Pepto-bismol<sup>®</sup> is not licensed for children younger than 16 years of age due to a possible association between salicylates and Reye's syndrome update [<a class="bibliography-reference internal-reference" href="../../references/index.html">MHRA, 2019</a>].  </li></ul></li><li>Probiotics are not recommended for the prevention of travellers' diarrhoea because of insufficient evidence to support their use [<a class="bibliography-reference internal-reference" href="../../references/index.html">CATMAT, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">CDC, 2017a</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>]. A meta-analysis found a statistically significant effect of probiotics in preventing travellers' diarrhoea. However, the findings were limited by methodological issues including different types of probiotics included in the studies, and different routes of administration [<a class="bibliography-reference internal-reference" href="../../references/index.html">Bae, 2018</a>]. </li><li>The WHO warns that antidiarrhoeal medicines such as loperamide are contraindicated for prophylactic use [<a class="bibliography-reference internal-reference" href="../../references/index.html">WHO, 2012</a>]<strong> </strong>and loperamide is not licensed for this purpose [<a class="bibliography-reference internal-reference" href="../../references/index.html">ABPI, 2018a</a>].</li></ul><h5>Considering 'stand-by' antibiotics</h5><ul><li>The use of 'stand-by' antibiotics for certain travellers is discussed in information from the UK National Travel Health Network and Centre (NathNac) [<a class="bibliography-reference internal-reference" href="../../references/index.html">NaTHNaC, 2016</a>], and the US Centers for Disease Control and Prevention [<a class="bibliography-reference internal-reference" href="../../references/index.html">CDC, 2017a</a>], in addition to guidance from the American College of Gastroenterologists [<a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2016</a>],<strong> </strong>and an expert consensus panel [<a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>]. <strong> </strong></li></ul><h5>Vaccinations</h5><ul><li>There is no universal vaccine to protect against the general syndrome of travellers' diarrhoea and no widely available vaccines for the most frequent causes of travellers' diarrhoea [<a class="bibliography-reference internal-reference" href="../../references/index.html">NaTHNaC, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Barrett and Brown, 2018</a>]. However, vaccines are available for some causes of gastrointestinal upset while travelling (for example hepatitis A and typhoid vaccines may be given prior to travel; rotavirus vaccine is part of the routine immunisation schedule for children in the UK) [<a class="bibliography-reference internal-reference" href="../../references/index.html">Barrett and Brown, 2018</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">PHE, 2018</a>]. <strong> </strong></li></ul><h5>Advice on self-management and seeking medical advice</h5><ul><li>This recommendation is extrapolated from advice in US guidelines on the prevention and treatment of travellers diarrhoea [<a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>] and expert opinion in review articles [<a class="bibliography-reference internal-reference" href="../../references/index.html">Leder, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Giddings et al, 2016</a>]. </li></ul><!-- end field e7463c4e-4ca2-4364-9faa-10d451b77dc9 --><!-- end item 72de8ce4-ab72-49b1-94ee-e9e5849774b2 --></div></section></section><section aria-labelledby="advice-on-food-drink" class="ChapterBody-module--wrapper--2HCfk "><h3 id="advice-on-food-drink">What food and drink measures are recommended for preventing travellers' diarrhoea?</h3><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item 2e156684-7871-487e-bdc7-d29ccb0a258c --><!-- begin field 463c6d77-7955-4e2b-a2bc-1a135aba8bf4 --><ul><li><strong>Advice on general hygiene</strong><ul><li>Hands should always be washed with soap and water before handling and consuming food (particularly after contact with raw meat and uncooked food), using the bathroom, or caring for an ill person.</li><li>If soap and water are not available, an alcohol-based hand sanitiser can be used as an alternative until it is possible to wash the hands. Note that hand sanitizer is not very effective when hands are greasy or visibly dirty and has limited effectiveness against <em>Cryptosporidium</em> and norovirus.</li></ul></li><li><strong>Advice on food and drink</strong><ul><li>Food must have been thoroughly cooked, and must remain steaming hot prior to serving.<ul><li>Raw fish and seafood should be avoided, as well as shellfish, and any meat or poultry that has not been thoroughly cooked.</li><li>Risks are associated with food from buffets, restaurants, and street vendors. Food from these sources should be avoided, if it has neither been kept hot, nor refrigerated or kept on ice.</li><li>Cooked food that has been in contact with raw food, or contains raw or uncooked eggs (such as homemade mayonnaise), should be avoided.</li></ul></li><li>If hygiene and sanitation are likely to be inadequate, avoid salads, uncooked vegetables, and unpasteurised fruit juices. Fruits and vegetables that can be peeled or shelled are suitable choices (fruits and vegetables with damaged skins should be avoided).</li><li>Ice should be avoided, unless it has been made from safe water.</li><li>Unpasteurized (raw) milk or cheese should be avoided.</li><li>Carbonated bottled beverages are usually safe to drink provided they are sealed.</li></ul></li><li><strong>Advice on drinking water</strong><ul><li>Tap water should be avoided for drinking, preparing food, making ice, cooking, and brushing teeth, unless there is reasonable certainty it is safe.</li><li>Bottled water is the safer choice for drinking water. The seal must not have been tampered with.</li><li>Water should be boiled (for at least 1 minute) if its safety for drinking is in doubt.</li><li>Other options include micropore filtering and the use of disinfectant preparations. These might be more relevant for people travelling to areas where there is little or no access to safe drinking water.</li></ul></li><li>Information in the form of a fact sheet on <a data-hyperlink-id="fc93993d-6fa9-4209-ae3c-a9ea00ee525a" href="https://travelhealthpro.org.uk/factsheet/44/food-and-water-hygiene">Food and Water Hygiene</a> is available on the Travel Health Pro website (<a data-hyperlink-id="980429a0-79d1-405b-80d4-a9ea00ee531d" href="https://travelhealthpro.org.uk/">travelhealthpro.org.uk</a>). The World Health Organization also produces a <a data-hyperlink-id="763fc289-372f-4fe3-b634-a9eb00e1acb0" href="https://www.who.int/foodsafety/publications/travellers/en/">Guide on safe food for travellers</a> (available at <a data-hyperlink-id="63024a2d-8517-4df3-8374-a9eb00e1acf3" href="https://www.who.int/">www.who.int</a>). </li></ul><!-- end field 463c6d77-7955-4e2b-a2bc-1a135aba8bf4 --><!-- end item 2e156684-7871-487e-bdc7-d29ccb0a258c --></div><section aria-labelledby="basis-for-recommendation-b89" class="ChapterBody-module--wrapper--2HCfk "><h4 id="basis-for-recommendation-b89">Basis for recommendation</h4><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item b896a214-2325-4c38-8024-9f63d296b959 --><!-- begin field 49dd9f40-efc2-4253-ab34-d9ddda1ad5fa --><h5>Advice on general hygiene</h5><ul><li>These recommendations are based on information issued by the World Health Organization (WHO) [<a class="bibliography-reference internal-reference" href="../../references/index.html">WHO, 2010</a>] and Canadian and US experts [<a class="bibliography-reference internal-reference" href="../../references/index.html">CATMAT, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">CDC, 2017b</a>]. The evidence on handwashing and use of alcohol-based hand sanitizers is mixed, but theoretically these measures should be the most effective to prevent enteric infection from organisms that can cause illness at low inoculum doses [<a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2016</a>]. <strong> </strong></li></ul><h5>Advice on food and drink</h5><ul><li>High-quality evidence that specific dietary measures can reduce the incidence of episodes of travellers' diarrhoea is lacking [<a class="bibliography-reference internal-reference" href="../../references/index.html">Barrett, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2016</a>], but considering that the majority of cases are caused by ingestion of contaminated food and water, it is thought that discussing food and water hygiene measures reduces the risk of developing travellers' diarrhoea [<a class="bibliography-reference internal-reference" href="../../references/index.html">Giddings et al, 2016</a>]. Factors beyond the control of the traveller may also influence the chances of travellers' diarrhoea (such as poor restaurant hygiene) [<a class="bibliography-reference internal-reference" href="../../references/index.html">Giddings et al, 2016</a>].   </li><li>However, experts suggest advising common sense with food selection [<a class="bibliography-reference internal-reference" href="../../references/index.html">Leder, 2015</a>], and the recommendations are based on suggestions from the World Health Organization [<a class="bibliography-reference internal-reference" href="../../references/index.html">WHO, 2012</a>],<strong> </strong>Canadian and US organisations [<a class="bibliography-reference internal-reference" href="../../references/index.html">CATMAT, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">CDC, 2017b</a>],<strong> </strong>and expert opinion [<a class="bibliography-reference internal-reference" href="../../references/index.html">Leder, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Barrett, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Barrett and Brown, 2018</a>]. </li></ul><h5>Advice on drinking water</h5><ul><li>These recommendations reflect advice from Canadian and US experts [<a class="bibliography-reference internal-reference" href="../../references/index.html">CATMAT, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">CDC, 2017b</a>].  </li></ul><!-- end field 49dd9f40-efc2-4253-ab34-d9ddda1ad5fa --><!-- end item b896a214-2325-4c38-8024-9f63d296b959 --></div></section></section><section aria-labelledby="advice-on-managing-travellers-diarrhoea" class="ChapterBody-module--wrapper--2HCfk "><h3 id="advice-on-managing-travellers-diarrhoea">What should I advise about self-management of travellers' diarrhoea?</h3><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item 6972c5c1-db5a-41cf-a929-179ec0d2fe1b --><!-- begin field 7152c672-3aaf-4436-b3a1-2ff85026ce28 --><ul><li><strong>Advise the person: </strong><ul><li>That most episodes of travellers' diarrhoea are short-lived and self-limiting, and last a few days. </li><li>To consider purchasing sachets of oral rehydration salts before travelling as they may not be available at the destination. </li></ul></li><li><strong>Advise that during an episode of diarrhoea:</strong><ul><li>It is important to prevent dehydration — particularly for young children, pregnant women, elderly people, and those with pre-existing illnesses.<ul><li>For infants, breastfeeding should not be interrupted.</li><li>Hydration must be maintained, for example with boiled, treated, or sealed bottled water. Most otherwise healthy adults can stay hydrated by eating and drinking as normal.</li><li>Alcohol and other drinks and beverages with a diuretic effect (such as coffee and tea) and overly sweet drinks (in large quantities) should be avoided.</li><li>For more severe symptoms, or people prone to complications from dehydration, oral rehydration powders diluted into clean drinking water also help to correct electrolyte imbalances.</li><li>Immediate medical attention is required if children show signs of dehydration such as restlessness or irritability, great thirst, sunken eyes, and dry skin with reduced elasticity.</li></ul></li><li>Symptomatic treatment with loperamide or bismuth subsalicylate (for example Pepto-Bismol<sup>®</sup>)<sup> </sup>may be considered for <em>adults </em>to relieve mild-to-moderate diarrhoea for a maximum of two days. <ul><li>Loperamide is usually considered the standard treatment when rapid control of symptoms is required — for example during travelling where toilet amenities are limited or unavailable. </li><li>Bismuth subsalicylate<sup> </sup>is more suitable for mild diarrhoea; loperamide has a faster onset of action and is more effective than bismuth subsalicylate<sup> </sup>for controlling diarrhoea and cramping.</li><li>Bismuth subsalicylate<sup> </sup>is not suitable for people with aspirin allergy, renal insufficiency, gout, severe enteric disease or HIV (risk of bismuth absorption), or people who are taking an anticoagulant such as warfarin, or pregnant or breastfeeding women. Darkened tongue and stools are common adverse effects.</li></ul></li></ul></li><li><strong>Advise the person <em>not </em>to use loperamide or bismuth subsalicylate (for example Pepto-Bismol<sup>®</sup>) if they have blood or mucous in the stool and/or high fever or severe abdominal pain. </strong></li><li><strong>Neither loperamide nor bismuth subsalicylate (for example Pepto-Bismol<sup>®</sup>) are recommended for children to relieve diarrhoeal symptoms. </strong><ul><li>Loperamide should not be used in children younger than 12 years of age because of concerns that it may cause intestinal obstruction. </li><li>Bismuth subsalicylate must not be used in children younger than 16 years of age because of the possible association between salicylates and Reye's syndrome. </li></ul></li><li><strong>Medical assistance must be sought if:</strong><ul><li>Stools are blood-stained, profuse and watery, or there is high or persistent fever or severe abdominal pain.</li><li>Severe diarrhoea occurs in infants or elderly people, or a child is unwell with travellers' diarrhoea and symptomatic treatment is needed.</li><li>The person becomes dehydrated — particularly in infants and children (restlessness or irritability, very thirsty, sunken eyes, and dry skin with reduced elasticity); or it is difficult to maintain adequate hydration.</li><li>Diarrhoea does not begin to improve within 24–36 hours despite self-treatment. </li><li>There is a medical comorbidity (for example immunosuppression or gastrointestinal disorder).</li></ul></li><li><strong>Advice for travellers can be found on the following websites: </strong><ul><li>NHS: <a data-hyperlink-id="d01cb68e-c87a-4756-890d-a93100a26471" href="http://www.nhs.uk/">www.nhs.uk</a>—<a data-hyperlink-id="a23ca0ce-46de-4b09-b12e-a93100a26488" href="http://www.nhs.uk/nhsengland/Healthcareabroad/pages/Healthcareabroad.aspx">Access to healthcare abroad</a>.</li><li>The National Travel Health Network and Centre (NaTHNaC): <a data-hyperlink-id="5eb1a444-fbec-422d-9dd0-a9dc00f16b28" href="https://nathnac.net/">www.nathnac.net</a>.</li><li>The 'Fit for travel' website provided by NHS Scotland: <a data-hyperlink-id="02de3528-2314-4c66-aa45-a93100a2648e" href="http://www.fitfortravel.scot.nhs.uk/home.aspx">www.fitfortravel.scot.nhs.uk</a>.</li><li>The World Health Organization: <a data-hyperlink-id="13cf18b0-745a-4425-9a8c-a93100a26594" href="http://www.who.int/ith/en/">www.who.int</a>.</li></ul></li></ul><!-- end field 7152c672-3aaf-4436-b3a1-2ff85026ce28 --><!-- end item 6972c5c1-db5a-41cf-a929-179ec0d2fe1b --></div><section aria-labelledby="basis-for-recommendation-79c" class="ChapterBody-module--wrapper--2HCfk "><h4 id="basis-for-recommendation-79c">Basis for recommendation</h4><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item 79c32cc3-f228-4eee-9b1d-8ddeb22306a5 --><!-- begin field 6a9e5ce7-978d-4a88-bdc8-0022f0a5b495 --><h5>Advice on usual timecourse of travellers' diarrhoea and purchasing oral rehydration salts</h5><ul><li>The information on the usual short-lived and self-limiting nature of an episode of travellers diarrhoea is based on information from the World Health Organization (WHO) [<a class="bibliography-reference internal-reference" href="../../references/index.html">WHO, 2012</a>]<strong> </strong>and the US Centers for Disease Control and Prevention [<a class="bibliography-reference internal-reference" href="../../references/index.html">CDC, 2017a</a>]. </li><li>The advice to consider purchasing oral rehydration salts before travelling reflects expert opinion in review articles on advising travellers about the management of travellers' diarrhoea [<a class="bibliography-reference internal-reference" href="../../references/index.html">Leder, 2015</a>] and travellers' diarrhoea in children [<a class="bibliography-reference internal-reference" href="../../references/index.html">Ashkenazi et al, 2016</a>]. </li></ul><h5>Measures to prevent dehydration</h5><ul><li>These recommendations are based on information issued by the WHO on international travel and health and safe food for travellers [<a class="bibliography-reference internal-reference" href="../../references/index.html">WHO, 2010</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">WHO, 2012</a>], UK advice for travellers from the National Travel Health Network and Centre (NaTHNaC) [<a class="bibliography-reference internal-reference" href="../../references/index.html">NaTHNaC, 2016</a>], and<strong> </strong>US and Canadian recommendations on travellers' diarrhoea [<a class="bibliography-reference internal-reference" href="../../references/index.html">CATMAT, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">CDC, 2017a</a>]. <strong> </strong></li></ul><h5>Symptomatic treatment for adults</h5><ul><li>Expert consensus guidance suggests that, given the concerns regarding potential adverse effects of antibiotics and antimicrobial resistance patterns, either increasing fluid intake or treatment with loperamide or bismuth subsalicylate may be sufficient for most people with mild travellers' diarrhoea [<a class="bibliography-reference internal-reference" href="../../references/index.html">CATMAT, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>]. <strong> </strong></li><li>CKS found limited evidence to support the use of bismuth subsalicylate and loperamide for travellers' diarrhoea in adults. Trials were generally of poor methodological quality. </li></ul><h5>Loperamide</h5><ul><li>Loperamide is recommended as an option to consider for the symptomatic treatment of mild to moderate travellers' diarrhoea by Canadian and US experts [<a class="bibliography-reference internal-reference" href="../../references/index.html">CATMAT, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">CDC, 2017a</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>], expert opinion in travel information for healthcare professionals<strong> </strong>[<a class="bibliography-reference internal-reference" href="../../references/index.html">NaTHNaC, 2016</a>], the British National Formulary [<a class="bibliography-reference internal-reference" href="../../references/index.html">BNF 76, 2018</a>], and review articles [<a class="bibliography-reference internal-reference" href="../../references/index.html">Steffen, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Giddings et al, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Barrett and Brown, 2018</a>].<strong> </strong>Loperamide reduces frequency of bowel movements, taking 1–2 hours to reach its therapeutic effect, and appears to have antisecretory properties [<a class="bibliography-reference internal-reference" href="../../references/index.html">CDC, 2017a</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>].  It has a well-established safety profile and is usually well-tolerated [<a class="bibliography-reference internal-reference" href="../../references/index.html">Steffen, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">CDC, 2017a</a>].  <ul><li>The evidence supporting the efficacy of loperamide for travellers' diarrhoea is stronger than that for bismuth subsalicylate [<a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>] but is still limited. There is very limited evidence from two small studies that loperamide can reduce the frequency of unformed stools in the early stages (within the first 24 hours) compared with placebo [<a class="bibliography-reference internal-reference" href="../../references/index.html">van Loon et al, 1989</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Ericsson et al, 1990</a>]. Other outcome measures (for example symptom reduction) are generally poorly reported. One small trial found no difference when loperamide was compared with loperamide plus oral rehydration salt solution [<a class="bibliography-reference internal-reference" href="../../references/index.html">Caeiro et al, 1999</a>]. <strong> </strong></li><li>A systematic review found a small amount of data comparing loperamide with antibiotics and found no proof of antibiotics being more effective for the treatment of travellers' diarrhoea. The review authors therefore advised antibiotics only for severe illness and noted the value of loperamide for symptom control, particularly given increasing antimicrobial resistance [<a class="bibliography-reference internal-reference" href="../../references/index.html">Laaveri et al, 2016</a>].  A subsequent guideline found no randomized controlled trial (RCT) evidence comparing loperamide with azithromycin or fluoroquinolones [<a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>]. <strong> </strong></li><li>There is weak evidence from two unblinded trials in students with travellers' diarrhoea that loperamide is more effective than bismuth subsalicylate at reducing the number of unformed stools in the initial stage of treatment (generally within the first 24 hours). However, the differences were small and the clinical significance is uncertain [<a class="bibliography-reference internal-reference" href="../../references/index.html">Johnson et al, 1986</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">DuPont et al, 1990</a>]. </li></ul></li></ul><h5>Bismuth subsalicylate</h5><ul><li>Bismuth subsalicylate is recommended as an option to consider for the symptomatic treatment of mild travellers' diarrhoea by a number of experts and organisations [<a class="bibliography-reference internal-reference" href="../../references/index.html">CATMAT, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">NaTHNaC, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">CDC, 2017a</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>]. It is well tolerated, with usually mild adverse effects in adults [<a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>],<strong> </strong>although it is slower to act than loperamide; may be less effective; cannot be used in a number of groups of people, and has the potential for interactions with a person's other medications [<a class="bibliography-reference internal-reference" href="../../references/index.html">Moore, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Giddings et al, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>]. <ul><li>There is limited evidence from two small RCTs that, compared with placebo, bismuth subsalicylate can reduce the number of unformed stools and the time to the last unformed stool. However, in both cases the differences were small [<a class="bibliography-reference internal-reference" href="../../references/index.html">DuPont et al, 1977</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Steffen et al, 1988</a>]. </li></ul></li></ul><h5>Recommended precautions for loperamide and bismuth subsalicylate (for example Pepto-Bismol<sup>®</sup>)</h5><ul><li>These are in line with information from NaTHNaC [<a class="bibliography-reference internal-reference" href="../../references/index.html">NaTHNaC, 2016</a>],<strong> </strong>the British National Formulary [<a class="bibliography-reference internal-reference" href="../../references/index.html">BNF 76, 2018</a>],<strong> </strong>and recommendations issued by the manufacturers of loperamide and bismuth subsalicylate [<a class="bibliography-reference internal-reference" href="../../references/index.html">ABPI, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">ABPI, 2018a</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">MHRA, 2019</a>]. </li><li>CKS's recommendation not to use loperamide or bismuth subsalicylate<sup> </sup>beyond 2 days is consistent with information from the manufacturers of loperamide and Pepto-Bismol<sup>® </sup>[<a class="bibliography-reference internal-reference" href="../../references/index.html">ABPI, 2018a</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">MHRA, 2019</a>], and US guidelines covering the management of acute diarrhoea infections in adults [<a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2016</a>]. </li><li>Loperamide should be avoided in people with fever or bloody diarrhoea, and in people with active inflammatory bowel disease [<a class="bibliography-reference internal-reference" href="../../references/index.html">NaTHNaC, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">CDC, 2017a</a>]; loperamide can inhibit peristalsis, resulting in complications such as ileus, megacolon, and toxic megacolon [<a class="bibliography-reference internal-reference" href="../../references/index.html">ABPI, 2018a</a>].<strong> </strong></li></ul><h5>Symptomatic treatment for children is not recommended</h5><ul><li>The recommendation to avoid loperamide in children younger than 12 years of age is in line with guidance from the WHO (which advises against the use of antimotility drugs because they may cause intestinal obstruction) and travel advice from NaTHNaC. This advises that parents seek early advice for children in this group who become unwell with travellers' diarrhoea and need symptomatic treatment, emphasising that rehydration is the main treatment for young children [<a class="bibliography-reference internal-reference" href="../../references/index.html">WHO, 2010</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">NaTHNaC, 2016</a>]. Loperamide is only licensed for use in children older than 12 years of age [<a class="bibliography-reference internal-reference" href="../../references/index.html">ABPI, 2018a</a>] and there is limited data on its use in children less than 12 years old [<a class="bibliography-reference internal-reference" href="../../references/index.html">ABPI, 2018b</a>]. </li><li>Bismuth salicylate (Pepto-Bismol<sup>®</sup>) is not licensed for use in children younger than 16 years of age because of the possible association between salicylates and Reye's syndrome [<a class="bibliography-reference internal-reference" href="../../references/index.html">ABPI, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">MHRA, 2019</a>]. It is also not recommended for children by Public Health England in recommendations on antimicrobial prescribing for travellers diarrhoea [<a class="bibliography-reference internal-reference" href="../../references/index.html">NICE and PHE, 2018</a>],<strong> </strong>and some experts also advise against its use in this group [<a class="bibliography-reference internal-reference" href="../../references/index.html">Moore, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Giddings et al, 2016</a>].  </li></ul><h5>When to seek medical assistance</h5><ul><li>The recommendations on when to seek medical assistance are in line with guidance issued by the WHO [<a class="bibliography-reference internal-reference" href="../../references/index.html">WHO, 2010</a>], the American College of Gastroenterology and an expert panel [<a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>], information published by NaTHNaC [<a class="bibliography-reference internal-reference" href="../../references/index.html">NaTHNaC, 2016</a>], and expert opinion [<a class="bibliography-reference internal-reference" href="../../references/index.html">Leder, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Moore, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Giddings et al, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Barrett and Brown, 2018</a>].  </li></ul><!-- end field 6a9e5ce7-978d-4a88-bdc8-0022f0a5b495 --><!-- end item 79c32cc3-f228-4eee-9b1d-8ddeb22306a5 --></div></section></section><section aria-labelledby="prophylactic-antibiotic-treatment-for-travellers-diarrhoea" class="ChapterBody-module--wrapper--2HCfk "><h3 id="prophylactic-antibiotic-treatment-for-travellers-diarrhoea">When should I consider prescribing a prophylactic antibiotic for travellers' diarrhoea?</h3><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item d0fc70c1-475a-4187-9545-553eff9d5828 --><!-- begin field 9938aaf5-37bf-41f7-8083-2e89c2c8b83a --><ul><li><strong>Do not routinely prescribe prophylactic antibiotic treatments for travellers' diarrhoea.</strong></li><li><strong>The decision to prescribe prophylactic antibiotic treatments depends on an assessment of:</strong><ul><li>The risk of the person developing travellers' diarrhoea (see <a class="topic-reference internal-reference" href="index.html#assessing-risk-before-travelling">Assessing risk (before travelling)</a>).</li><li>The potential harm to the person if they were to develop travellers' diarrhoea.</li><li>The benefits and risks of antibiotic treatment. </li><li>Access to medical assistance while travelling.</li></ul></li><li><strong>Consider prophylactic antibiotic treatment only for people who are at </strong><a class="topic-reference internal-reference" href="index.html#assessing-risk-before-travelling">high risk</a><strong> of travellers' diarrhoea and its consequences — seek specialist advice before prescribing. </strong>The National Travel Health Network and Centre (NaTHNaC) provides a telephone advice line for health professionals advising travellers with complex itineraries or specialist health needs. For more information, see the NaTHNaC website (<a data-hyperlink-id="ff0ce7ad-1991-401e-bc72-a9f3009f9367" href="https://nathnac.net/">www.nathnac.net</a>).<strong> </strong>Groups who may benefit from prophylactic treatment include those who:<ul><li>Have increased susceptibility to infection or are immunocompromised.</li><li>Have a high risk of complications if they were to develop travellers' diarrhoea, for example:<ul><li>People with chronic gastrointestinal disease (such as Crohn's disease, or ulcerative colitis). </li><li>People with an ileostomy or colostomy.</li><li>People with other diseases (such as malignancy, type 1 diabetes mellitus, renal disease, stroke, congestive heart failure, or sickle cell disease) in whom a diarrhoeal illness might severely impact on their health.</li></ul></li><li>Have a history of significant long-term morbidity after an enteric infection (for example reactive arthritis).</li><li>Are undertaking critical trips in which a short bout of diarrhoea could severely impact the purpose of the trip (for example athlete, politician, professional musician, lecturer).</li><li>May not have access to adequate medical treatment if they experience complicated travellers' diarrhoea.</li></ul></li></ul><!-- end field 9938aaf5-37bf-41f7-8083-2e89c2c8b83a --><!-- end item d0fc70c1-475a-4187-9545-553eff9d5828 --></div><section aria-labelledby="basis-for-recommendation-1c7" class="ChapterBody-module--wrapper--2HCfk "><h4 id="basis-for-recommendation-1c7">Basis for recommendation</h4><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item 1c798dd5-177a-4840-a363-08a2be834124 --><!-- begin field 0e5c3205-38bf-4fca-8a6e-d73f668fe475 --><h5>Avoiding routine prophylactic treatment</h5><ul><li>Antibiotic prophylaxis has been shown in studies to give up to 90% protection against developing travellers' diarrhoea, although effectiveness depends on the choice of antibiotic and the area of travel [<a class="bibliography-reference internal-reference" href="../../references/index.html">Giddings et al, 2016</a>]. </li><li>However, the World Health Organization (WHO) warns that the use of prophylactic antibiotics is controversial [<a class="bibliography-reference internal-reference" href="../../references/index.html">WHO, 2012</a>]<strong> </strong>(with some experts not recommending this [<a class="bibliography-reference internal-reference" href="../../references/index.html">NIH Consensus Development Program, 1985</a>]). More recent guidelines also emphasise the growing problem of antibiotic resistance associated with travellers' diarrhoea and self-treatment and its potential consequences for individual and population health [<a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>].  </li><li>The recommendations on avoidance of routine use of antibiotic prophylaxis and factors to consider when deciding whether prophylactic treatment may be an option are supported by UK, US, and Canadian experts [<a class="bibliography-reference internal-reference" href="../../references/index.html">CATMAT, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">CDC, 2017a</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">NICE and PHE, 2018</a>]. Reasons for not routinely prescribing antibiotic prophylaxis include [<a class="bibliography-reference internal-reference" href="../../references/index.html">WHO, 2012</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">CATMAT, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Leder, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">CDC, 2017a</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>]: <ul><li>For most people, travellers' diarrhoea is mild and self-limiting.</li><li>Antibiotic prophylaxis offers no protection against non-bacterial causes of travellers' diarrhoea (such as viruses and parasites).</li><li>Removal of normally protective microflora from the bowel with prophylactic antibiotics can increase the risk of infection with resistant bacteria.</li><li>Use of prophylactic antibiotics reduces the choices for treatment if required for travellers' diarrhoea.</li><li>Taking antibiotic prophylaxis may give the traveller a false sense of security, which might lead to neglect of food and water precautions.</li><li>The increasing prevalence of antibiotic resistance is of concern (including to fluoroquinolones).</li><li>No antibiotics are licensed in the UK for the prophylaxis of travellers' diarrhoea.</li><li>Antibiotic treatment can lead to adverse effects and routine use of antibiotics for prophylaxis could expose the person to risks greater than that of the illness.</li></ul></li></ul><h5>When to consider prophylactic treatment</h5><ul><li><p>Some organisations and experts acknowledge that there is a role for the use of prophylactic antibiotics in certain high risk groups of travellers [<a class="bibliography-reference internal-reference" href="../../references/index.html">WHO, 2012</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Leder, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Steffen, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Giddings et al, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">CDC, 2017a</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Barrett and Brown, 2018</a>], with US guidelines discussing potential benefit for travellers at high risk of travellers' diarrhoea and susceptible to potentially serious health consequences [<a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2016</a>]. However, UK antimicrobial prescribing guidance issued by Public Health England states that prophylaxis is rarely, if ever indicated [<a class="bibliography-reference internal-reference" href="../../references/index.html">NICE and PHE, 2018</a>]<strong> </strong>and US guidelines on the prevention and treatment of travellers' diarrhoea advises self treatment of moderate to severe travellers' diarrhoea as the standard approach, with 'chemoprophylaxis the rare exception'<strong> </strong>[<a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>]. </p><ul><li><p>There is a lack of evidence to support the effectiveness of antibiotic prophylaxis for people travelling to countries with low or intermediate risk of travellers' diarrhoea. One double-blind trial in 127 participants found antibiotic treatment (norfloxacin) to be effective in reducing the number of Swedish travellers developing diarrhoea in high-risk countries (Africa, Asia, or Latin America, p = 0.0004) but not for those travelling to low-risk countries (Mediterranean Europe or the Canary Islands) [<a class="bibliography-reference internal-reference" href="../../references/index.html">Wiström et al, 1987</a>].</p></li></ul></li><li><p>The groups of travellers for whom antibiotic prophylaxis may be considered are in line with recommendations issued by the WHO [<a class="bibliography-reference internal-reference" href="../../references/index.html">WHO, 2012</a>], along with guidelines from the US and an advisory committee statement from Canada [<a class="bibliography-reference internal-reference" href="../../references/index.html">CATMAT, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">CDC, 2017a</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>], and expert opinion [<a class="bibliography-reference internal-reference" href="../../references/index.html">DuPont, 2008</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">DuPont et al, 2009</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Leder, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Steffen, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Barrett, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Giddings et al, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">DuPont and Steffen, 2017</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Taylor et al, 2017</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Barrett and Brown, 2018</a>]. </p></li></ul><h5>Seeking specialist advice if prophylactic antibiotic treatment is being considered</h5><ul><li>Planning prophylactic treatment is complex due to geographic variation and the large number of potential pathogens, particularly if the person has a comorbidity (for example requiring immunosuppressant medication) [<a class="bibliography-reference internal-reference" href="../../references/index.html">Zaidi and Wine, 2015</a>], and the prophylactic treatment options discussed by experts all have their limitations.<strong> </strong>For example: <ul><li>Fluoroquinolones have evidence to support their role as prophylactic treatment for travellers' diarrhoea, but their use is limited by emerging resistance, particularly to <em>Campylobacter</em> in Nepal and Thailand and types of <em>E. coli</em> in India, which may mean their efficacy is now less than suggested by historic trials [<a class="bibliography-reference internal-reference" href="../../references/index.html">CATMAT, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">CDC, 2017a</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>]. Their safety profile may be considered to be unacceptable for a prophylactic indication, due to serious adverse effects such as cartilage damage, tendon rupture, and <em>C. difficile-</em>associated diarrhoea [<a class="bibliography-reference internal-reference" href="../../references/index.html">CATMAT, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2016</a>]. In addition, use of fluoroquinolones for prophylaxis limits therapeutic options if travellers' diarrhoea develops [<a class="bibliography-reference internal-reference" href="../../references/index.html">Taylor et al, 2017</a>]. <strong> </strong></li><li>Rifaximin is a non-absorbable antibiotic for which there is evidence of efficacy (although it does not prevent all cases of travellers' diarrhoea), with a favourable safety profile [<a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Taylor et al, 2017</a>]. It is not associated with antmicrobial resistance in travellers and does not appear to modify the gut microflora [<a class="bibliography-reference internal-reference" href="../../references/index.html">CATMAT, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Taylor et al, 2017</a>], but <em>Campylobacter</em> is not susceptible, meaning it only offers moderate protection in South and South East Asia [<a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>]. <strong> </strong></li><li>Azithromycin is lacking in evidence to support its use as a prophylactic agent for travellers' diarrhoea [<a class="bibliography-reference internal-reference" href="../../references/index.html">CATMAT, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Taylor et al, 2017</a>]<strong> </strong>and is useful as a therapeutic option for travellers' diarrhoea, particularly in South and South East Asia [<a class="bibliography-reference internal-reference" href="../../references/index.html">Leder, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Giddings et al, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Taylor et al, 2017</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Barrett and Brown, 2018</a>] and in cases of dysentery [<a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>].  </li></ul></li><li>Public Health England antimicrobial prescribing guidance does not offer an antibiotic option for prophylaxis of travellers' diarrhoea [<a class="bibliography-reference internal-reference" href="../../references/index.html">NICE and PHE, 2018</a>]. Taking this into account, along with the uncertainty regarding choice of prophylactic antibiotic treatment, its disadvantages, and the mixed opinion on which groups of people are likely to benefit, CKS has recommended seeking specialist advice if considering prescribing antibiotic prophylaxis for the prevention of travellers' diarrhoea.</li></ul><!-- end field 0e5c3205-38bf-4fca-8a6e-d73f668fe475 --><!-- end item 1c798dd5-177a-4840-a363-08a2be834124 --></div></section></section><section aria-labelledby="stand-by-antibiotic-treatment-for-travellers-diarrhoea" class="ChapterBody-module--wrapper--2HCfk "><h3 id="stand-by-antibiotic-treatment-for-travellers-diarrhoea">When should I prescribe a 'stand-by' antibiotic for treatment of travellers' diarrhoea?</h3><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item cb6d0548-400f-47c7-8683-3fd6e15aa3ea --><!-- begin field e5d76334-7b02-4f0d-be5b-30066d62fe85 --><ul><li><strong>Do not routinely prescribe 'stand-by' (to be used if affected) treatments for travellers' diarrhoea.</strong></li><li><strong>Consider a 'stand-by' (to be used if affected) antibiotic for people who are:</strong><ul><li>Travelling to high-risk locations (especially where access to medical assistance is poor or not available, or there is doubt about the safety and purity of antibiotics available at their destination). </li><li>At high risk of severe illness.</li></ul></li><li><strong>Seek specialist advice if considering prescribing a 'stand-by' antibiotic. </strong><ul><li>The National Travel Health Network and Centre (NaTHNaC) provides a telephone advice line for health professionals advising travellers with complex itineraries or specialist health needs. For more information, see the NaTHNaC website (<a data-hyperlink-id="d63e515a-0c04-4b91-90ef-a9f300a0daff" href="https://nathnac.net/">www.nathnac.net</a>).</li></ul></li></ul><!-- end field e5d76334-7b02-4f0d-be5b-30066d62fe85 --><!-- end item cb6d0548-400f-47c7-8683-3fd6e15aa3ea --></div><section aria-labelledby="basis-for-recommendation-ba9" class="ChapterBody-module--wrapper--2HCfk "><h4 id="basis-for-recommendation-ba9">Basis for recommendation</h4><div class="ChapterBody-module--body--2n0CK" aria-hidden="false"><!-- begin item ba907d36-6d08-485a-979a-c2cba2c22724 --><!-- begin field 62bf8133-b9c4-471f-881e-a2928145ad27 --><h5>Not routinely offering a 'stand-by' antibiotic</h5><ul><li>Most cases of travellers' diarrhoea are mild and self-limiting and will resolve without treatment [<a class="bibliography-reference internal-reference" href="../../references/index.html">CATMAT, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Giddings et al, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>].  </li><li>Risks of providing 'stand-by' antibiotics have also been highlighted, such as increasing antimicrobial resistance [<a class="bibliography-reference internal-reference" href="../../references/index.html">Laaveri et al, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Taylor et al, 2017</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Barrett and Brown, 2018</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle et al, 2018</a>]. The use of antibiotics for travellers' diarrhoea has been associated with acquiring extended-spectrum beta-lactamase (ESBL) enterobacteriacae organisms, which may be harmful to certain groups of people, for example those who are immunocompromised or prone to urinary tract infections [<a class="bibliography-reference internal-reference" href="../../references/index.html">Kantele et al, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Giddings et al, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Kantele et al, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">CDC, 2017a</a>]. Use of antibiotics may also influence the traveller's microbiota, potentially leading to infection with <em>Clostridium difficile</em> [<a class="bibliography-reference internal-reference" href="../../references/index.html">CDC, 2017a</a>]. </li><li>Some experts recommend that most, if not all, travellers should have an antibiotic for self treatment [<a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>]. However, others have questioned the routine use of empirical antibiotics [<a class="bibliography-reference internal-reference" href="../../references/index.html">Taylor et al, 2017</a>] and an advisory committee advises limited use of antibiotics for the treatment of travellers' diarrhoea [<a class="bibliography-reference internal-reference" href="../../references/index.html">CATMAT, 2015</a>]. </li></ul><h5>When to consider prescribing a 'stand-by' antibiotic </h5><ul><li>The recommendations on when to consider providing a ‘stand-by’ antibiotic for an adult are based on Public Health England antimicrobial prescribing guidance [<a class="bibliography-reference internal-reference" href="../../references/index.html">NICE and PHE, 2018</a>]<strong> </strong>and expert opinion in review articles [<a class="bibliography-reference internal-reference" href="../../references/index.html">Giddings et al, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Barrett and Brown, 2018</a>]. In making a decision about prescribing 'stand-by' treatment, US experts advise that the advantages of antibiotic treatment should be considered alongside concerns about the traveller and antibiotics [<a class="bibliography-reference internal-reference" href="../../references/index.html">CDC, 2017a</a>]. </li><li>There is evidence that antibiotics reduce the duration of illness to about one and a half days [<a class="bibliography-reference internal-reference" href="../../references/index.html">Steffen, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>], have the advantages of reducing the stress and inconvenience of changing travel plans, and avoid the need for a traveller to seek care at their destination from local providers which may be ineffective or unsafe. There is also the possibility that early antibiotic treatment may reduce the risk of chronic sequelae such as irritable bowel syndrome [<a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>].</li></ul><h5>Seeking specialist advice if considering a 'stand-by' antibiotic</h5><ul><li>CKS recommends seeking specialist advice if considering prescribing a 'stand-by' antibiotic for travellers' diarrhoea because of the complexities surrounding the appropriate choice and the need to take into account a number of factors including efficacy, destination (and associated likely pathogens and resistance patterns), potential for adverse effects, and acceptability of the treatment regimen [<a class="bibliography-reference internal-reference" href="../../references/index.html">Steffen, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Giddings et al, 2016</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>]. Possible options for 'stand-by' antibiotic treatment (on specialist advice) include:<ul><li>Azithromycin — although it is not licensed for the treatment of travellers' diarrhoea [<a class="bibliography-reference internal-reference" href="../../references/index.html">ABPI, 2018c</a>],<strong> </strong>azithromycin is particularly useful if there is severe travellers' diarrhoea, dysentery, high fever, travel to south and south East Asia, and if rifaximin is used as prophylaxis [<a class="bibliography-reference internal-reference" href="../../references/index.html">Leder, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">CDC, 2017a</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Barrett and Brown, 2018</a>].<strong> </strong>Azithromycin is well-tolerated by most people, and has a more convenient dosing schedule compared with quinolones [<a class="bibliography-reference internal-reference" href="../../references/index.html">Leder, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>]. </li><li>Fluoroquinolones — these are effective in much of the developing world, but their potential use is limited due to increasing fluoroquinolone resistance in <em>Campylobacter, Shigella</em>, and <em>Salmonella</em> species, particularly in South and South East Asia, where a significant proportion of travellers' diarrhoea is due to <em>Campylobacter</em> [<a class="bibliography-reference internal-reference" href="../../references/index.html">Leder, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">CDC, 2017a</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Taylor et al, 2017</a>]. Fluoroquinolones also may be less effective in cases of dysentery as these may be caused by a fluoroquinolone-resistant <em>Campylobacter</em> or <em>Shigella</em> species [<a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>]. There have also been concerns about the adverse effect profile of fluoroquinolones, including tendon rupture,<em> C. difficile </em>infection, and prolongation of the QT interval [<a class="bibliography-reference internal-reference" href="../../references/index.html">CDC, 2017a</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>]. </li><li>Rifaximin — this antibiotic is licensed for the treatment of travellers' diarrhoea that is not associated with fever, bloody diarrhoea, blood or leucocytes in the stools [<a class="bibliography-reference internal-reference" href="../../references/index.html">ABPI, 2017</a>].<strong> </strong>Although there is evidence that rifaximin is effective for treating travellers' diarrhoea compared with placebo and has similar efficacy to fluoroquinolones in non-invasive travellers' diarrhoea [<a class="bibliography-reference internal-reference" href="../../references/index.html">CATMAT, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Steffen, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Riddle, 2017</a>], it is not effective for treating diarrhoea caused by invasive enteric pathogens such as <em>Salmonella</em>, <em>Shigella</em>, or <em>Campylobacter </em>[<a class="bibliography-reference internal-reference" href="../../references/index.html">Steffen, 2015</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">ABPI, 2017</a>; <a class="bibliography-reference internal-reference" href="../../references/index.html">Tribble, 2017</a>]. </li></ul></li></ul><!-- end field 62bf8133-b9c4-471f-881e-a2928145ad27 --><!-- end item ba907d36-6d08-485a-979a-c2cba2c22724 --></div></section></section></section></div></div></div><div class="BackToTop-module--wrapper--2Z0EU"><nav aria-labelledby="back-to-top-link" class="BackToTop-module--nav--1DPZ6"><a class="BackToTop-module--anchor--1Nia6" id="back-to-top-link" href="index.html#content-start"><div class="container"><svg width="1em" height="1em" viewBox="0 0 512 512" fill="none" class="icon" aria-hidden="true" focusable="false"><path d="M478.152 338.576c0 10.091-3.525 18.661-10.576 25.712l-21.424 21.424c-7.243 7.243-15.909 10.864-26 10.864-10.283 0-18.853-3.621-25.712-10.864L255.576 247.136 116.712 385.712c-6.859 7.243-15.429 10.864-25.712 10.864s-18.853-3.621-25.712-10.864l-21.424-21.424C36.621 357.429 33 348.859 33 338.576c0-10.091 3.621-18.757 10.864-26l186-186c7.051-7.051 15.621-10.576 25.712-10.576 9.909 0 18.576 3.525 26 10.576l185.712 186c7.243 7.243 10.864 15.909 10.864 26z" fill="currentColor"></path></svg> Back to top</div></a></nav></div></main><footer class="Footer-module--footer--2QrGZ"><div class="Footer-module--container--1iuoB"><a href="https://www.nice.org.uk/" class="Footer-module--logo--3DGKv" aria-label="Go to NICE home page"></a><nav class="Services-module--wrapper--2qOoE" aria-label="Our services"><ul class="Services-module--list--3SZQu"><li><a href="https://pathways.nice.org.uk/" class="Services-module--link--2y_1q">NICE Pathways</a></li><li><a href="https://www.nice.org.uk/guidance" class="Services-module--link--2y_1q">NICE guidance</a></li><li><a href="https://www.nice.org.uk/standards-and-indicators" class="Services-module--link--2y_1q">Standards and indicators</a></li><li><a href="https://www.evidence.nhs.uk/" class="Services-module--link--2y_1q">Evidence search</a></li><li><a href="https://bnf.nice.org.uk/" class="Services-module--link--2y_1q"><abbr title="British National Formulary">BNF<!-- --> <span class="Services-module--visuallyHidden--t9mfm">British National Formulary</span></abbr><span aria-hidden="true" class="Services-module--tooltip--pg3nW">British National Formulary</span></a></li><li><a href="https://bnfc.nice.org.uk/" class="Services-module--link--2y_1q"><abbr title="British National Formulary for Children">BNFC<!-- --> <span class="Services-module--visuallyHidden--t9mfm">British National Formulary for Children</span></abbr><span aria-hidden="true" class="Services-module--tooltip--pg3nW">British National Formulary for Children</span></a></li><li><a href="../../../../index.html" aria-current="true" class="Services-module--link--2y_1q"><abbr title="Clinical Knowledge Summaries">CKS<!-- --> <span class="Services-module--visuallyHidden--t9mfm">Clinical Knowledge Summaries</span></abbr><span aria-hidden="true" class="Services-module--tooltip--pg3nW">Clinical Knowledge Summaries</span></a></li><li><a href="https://www.nice.org.uk/about/what-we-do/evidence-services/journals-and-databases" class="Services-module--link--2y_1q">Journals and databases</a></li></ul></nav><nav class="Pages-module--wrapper--30REl"><ul class="Pages-module--list--vvSk4"><li><a href="https://www.nice.org.uk/about">About NICE</a></li><li><a href="https://www.nice.org.uk/about/what-we-do/into-practice">Into practice</a></li><li><a href="https://www.nice.org.uk/get-involved">Get involved with NICE</a></li><li><a href="https://www.nice.org.uk/get-involved/jobs">Jobs</a></li><li><a href="https://www.nice.org.uk/news">News</a></li><li><a href="https://www.nice.org.uk/news/nice-newsletters-and-alerts">Newsletters and alerts</a></li><li><a href="https://www.nice.org.uk/get-involved/contact-us">Contact us</a></li><li><a href="https://www.nice.org.uk/leave-feedback">Leave feedback</a></li><li><a href="https://www.nice.org.uk/re-using-our-content">Reusing our content</a></li><li><a href="https://www.nice.org.uk/re-using-our-content/uk-open-content-licence">NICE UK Open Content Licence</a></li><li><a href="https://www.nice.org.uk/about/what-we-do/nice-syndication-api">Syndicate our content</a></li></ul></nav><div class="Social-module--wrapper--2nKsd"><ul class="Social-module--list--E5R5J" aria-label="NICE on social media"><li><a href="https://en-gb.facebook.com/NationalInstituteforHealthandCareExcellence/">Facebook</a></li><li><a href="https://twitter.com/NICEcomms">Twitter</a></li><li><a href="https://www.youtube.com/user/NICEmedia">YouTube</a></li><li><a href="https://www.instagram.com/nicecomms/">Instagram</a></li><li><a href="https://www.linkedin.com/company/national-institute-for-health-and-clinical-excellence">LinkedIn</a></li></ul></div></div><div class="Legal-module--wrapper--3AYMO"><div class="Legal-module--container--3TTBh"><nav class="Legal-module--menu--1e1Iy" aria-label="Legal menu"><ul><li><a href="https://www.nice.org.uk/accessibility">Accessibility</a></li><li><a href="https://www.nice.org.uk/freedom-of-information">Freedom of information</a></li><li><a href="https://www.nice.org.uk/glossary">Glossary</a></li><li><a href="https://www.nice.org.uk/terms-and-conditions">Terms and conditions</a></li><li><a href="https://www.nice.org.uk/privacy-notice">Privacy notice</a></li><li><a href="https://www.nice.org.uk/cookies">Cookies</a></li></ul></nav><p class="Legal-module--copyright--34nsI">©<!-- --> <abbr title="National Institute for Health and Care Excellence">NICE</abbr> <!-- -->2021<!-- -->. All rights reserved. Subject to<!-- --> <a href="https://www.nice.org.uk/terms-and-conditions#notice-of-rights">Notice of rights</a>.</p></div></div></footer></div><div id="gatsby-announcer" style="position:absolute;top:0;width:1px;height:1px;padding:0;overflow:hidden;clip:rect(0, 0, 0, 0);white-space:nowrap;border:0" aria-live="assertive" aria-atomic="true"></div></div><script id="gatsby-script-loader">/*<![CDATA[*/window.pagePath="/topics/diarrhoea-prevention-advice-for-travellers/management/diarrhoea-prevention-advice-for-travellers/";/*]]>*/</script><script id="gatsby-chunk-mapping">/*<![CDATA[*/window.___chunkMapping={"polyfill":["/polyfill-2cb897c2a056d28c9332.js"],"app":["/app-53a71c38b210970893c4.js"],"component---cache-caches-gatsby-plugin-offline-app-shell-js":["/component---cache-caches-gatsby-plugin-offline-app-shell-js-258fa972005c75a2a109.js"],"component---src-pages-404-tsx":["/component---src-pages-404-tsx.4b20f8dadfa146d0f95d.css","/component---src-pages-404-tsx-db046304e34e9a4e982b.js"],"component---src-pages-about-development-tsx":["/component---src-pages-about-development-tsx.4c5b5dd941fb0f6fd929.css","/component---src-pages-about-development-tsx-a805dcaba6372bd3fd34.js"],"component---src-pages-about-index-tsx":["/component---src-pages-about-index-tsx.a9a4b7f951b698486005.css","/component---src-pages-about-index-tsx-d5e998d3f688352286e1.js"],"component---src-pages-index-tsx":["/component---src-pages-index-tsx.49dafffcf9ae0c5f0d9f.css","/component---src-pages-index-tsx-6cc2ff789de11ec327f6.js"],"component---src-pages-search-tsx":["/component---src-pages-search-tsx.f915457cd8b05c27e895.css","/component---src-pages-search-tsx-a51f99760cb0d47808e2.js"],"component---src-pages-specialities-tsx":["/component---src-pages-specialities-tsx.fc62cf637c7ba1e609e7.css","/component---src-pages-specialities-tsx-90b8d3e5a5a3bff52a17.js"],"component---src-pages-topics-tsx":["/component---src-pages-topics-tsx.dfa0c1027e3cbeb11bdc.css","/component---src-pages-topics-tsx-960f75c13acbee11c017.js"],"component---src-pages-whats-new-tsx":["/component---src-pages-whats-new-tsx.7f7660f22ce5e07ac85a.css","/component---src-pages-whats-new-tsx-f78b713a66b42005fd9f.js"],"component---src-templates-chapter-level-1-chapter-level-1-tsx":["/component---src-templates-chapter-level-1-chapter-level-1-tsx.1a16ce552cccd7e50c41.css","/component---src-templates-chapter-level-1-chapter-level-1-tsx-0a03778bb80ba711929e.js"],"component---src-templates-chapter-level-2-chapter-level-2-tsx":["/component---src-templates-chapter-level-2-chapter-level-2-tsx.d09ef71dfbb262c31a03.css","/component---src-templates-chapter-level-2-chapter-level-2-tsx-3330d13663fb7ba90e1c.js"],"component---src-templates-speciality-speciality-tsx":["/component---src-templates-speciality-speciality-tsx.fc62cf637c7ba1e609e7.css","/component---src-templates-speciality-speciality-tsx-3357943d471e489a1b5f.js"],"component---src-templates-topic-topic-tsx":["/component---src-templates-topic-topic-tsx.afc04214919e241c3c2e.css","/component---src-templates-topic-topic-tsx-f17fe03d0b9a54a96aea.js"]};/*]]>*/</script><script src="../../../../polyfill-2cb897c2a056d28c9332.js" nomodule=""></script><script src="../../../../component---src-templates-chapter-level-2-chapter-level-2-tsx-3330d13663fb7ba90e1c.js" async=""></script><script src="../../../../0ad1f03a47300760909b2ab244b34289611800a7-fa70b32ffeeba2673019.js" async=""></script><script src="../../../../b95b9d9ffa67e6928854e772968693a58a7317d7-a9e1e5c953d4eee49b87.js" async=""></script><script src="../../../../app-53a71c38b210970893c4.js" async=""></script><script src="../../../../framework-34da02e39e1f104d9937.js" async=""></script><script src="../../../../webpack-runtime-28c424ef71f39faedaf0.js" async=""></script></body></html>